syndrome	score	normalized_score
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIa; GP3A;;GP IIIa;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	2.0	100.0
MYOCLONIC EPILEPSY OF LAFORA	1.5181308	75.90654
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	75.0
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	1.492658882	74.6329441
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	1.334248751	66.71243755
D-2-HYDROXYGLUTARIC ACIDURIA 1	1.311283633	65.56418165
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	65.27777999999999
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	1.1	55.00000000000001
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0833333	54.166665
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0833333	54.166665
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1.0819398	54.09699
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	1.0566039500000002	52.83019750000001
ABLEPHARON-MACROSTOMIA SYNDROME	1.0434783	52.173915
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.042044382	52.1022191
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.032261813	51.613090650000004
SPLENOPORTAL VASCULAR ANOMALIES	1.01955679	50.9778395
TRANSSEXUALITY	1.0188679	50.943395
MOWAT-WILSON SYNDROME; MOWS	1.018788611	50.93943055
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	1.015922412	50.79612060000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.015444863	50.772243149999994
#615207 IL21R IMMUNODEFICIENCY	1.0151515	50.757575
WILSON DISEASE	1.0151515	50.757575
MEVALONIC ACIDURIA; MEVA	1.013772082	50.6886041
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	1.0133333	50.666665
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	1.012123761	50.60618805
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.00724638	50.362319
FRONTONASAL DYSPLASIA 1; FND1	1.00704225	50.352112500000004
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	1.00440529	50.2202645
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.001759633	50.08798165
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	1.001759633	50.08798165
HYDROXYKYNURENINURIA	1.000843882	50.0421941
PHEOCHROMOCYTOMA	1.0	50.0
HAMAMY SYNDROME; HMMS	1.0	50.0
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0	50.0
AGENESIS OF CEREBRAL WHITE MATTER	1.0	50.0
HEPATOCELLULAR CARCINOMA	1.0	50.0
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.0	50.0
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.0	50.0
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	1.0	50.0
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	1.0	50.0
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	50.0
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	47.420629999999996
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.8831414430000001	44.157072150000005
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.8600871099999999	43.004355499999996
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.765549782	38.277489100000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	31.94443
HALOTHANE HEPATITIS	0.6147059	30.735295
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.6065888	30.32944
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.6043237330000001	30.216186650000004
BARE LYMPHOCYTE SYNDROME, TYPE II	0.6	30.0
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.6	30.0
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.6	30.0
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.5864633810000001	29.323169050000004
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.584248751	29.212437549999997
THROMBOCYTOPENIA 1	0.583333	29.16665
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.583333	29.16665
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.583333	29.16665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.5745504300000001	28.7275215
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.5555556	27.777780000000003
TRICHOHEPATOENTERIC SYNDROME 1	0.5484848	27.42424
COMBINED SAPOSIN DEFICIENCY	0.54645102	27.322551
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.543402351	27.17011755
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.542558	27.1279
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	26.8885991
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	26.785715
Congenital disorder of glycosylation, type IIh	0.532532282	26.6266141
AICARDI-GOUTIERES SYNDROME 5	0.529781502	26.489075099999997
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.526958162	26.3479081
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.52641052	26.320526
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.516067251	25.803362549999996
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	25.735295
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.51008711	25.5043555
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.508090262	25.4045131
IMMUNODEFICIENCY 36; IMD36	0.50440529	25.2202645
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.501759633	25.087981650000003
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.501759633	25.087981650000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.501759633	25.087981650000003
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.500915751	25.04578755
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.500915751	25.04578755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.500843882	25.0421941
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	25.0
IMMUNE DEFICIENCY DISEASE	0.5	25.0
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	25.0
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	25.0
247150 LIP PRINTS	0.5	25.0
PHLEBECTASIA OF LIPS	0.5	25.0
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	25.0
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.5	25.0
BRANCHIOOTORENAL SYNDROME 1	0.5	25.0
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.49992053299999994	24.996026649999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.49956068200000003	24.978034100000002
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	23.318445
CENTRALOPATHIC EPILEPSY	0.4484126	22.42063
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	22.420629999999996
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	22.420629999999996
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.416667	20.83335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.395164382	19.758219099999998
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.3868371	19.341855
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.3866966810000001	19.334834050000005
PSEUDOXANTHOMA ELASTICUM; PXE	0.38361402	19.180701
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	19.123935
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	19.123935
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.379680632	18.9840316
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	18.76369
EPILEPSY, JUVENILE ABSENCE	0.3752738	18.76369
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.372024453	18.60122265
AICARDI SYNDROME; AIC	0.3704545	18.522725
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.36383518	18.191758999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.362568782	18.128439099999998
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	18.06758
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	17.98244
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	17.4900941
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	17.401944999999998
PROPIONIC ACIDEMIA	0.34802083300000003	17.40104165
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.34574305099999997	17.28715255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.341619382	17.0809691
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.341495131	17.07475655
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.341495131	17.07475655
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.33901482	16.950741
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.33509263300000003	16.75463165
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.33509263300000003	16.75463165
ALSTROM SYNDROME; ALMS	0.334569702	16.7284851
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.334248751	16.71243755
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.334248751	16.71243755
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.334248751	16.71243755
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.334176882	16.7088441
GRANGE SYNDROME; GRNG	0.333333	16.66665
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.333333	16.66665
PARAGANGLIOMAS 3	0.333333	16.66665
PSEUDO-VON WILLEBRAND DISEASE	0.333333	16.66665
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.333333	16.66665
Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	0.333333	16.66665
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.333333	16.66665
PARAGANGLIOMAS 4	0.333333	16.66665
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.333333	16.66665
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.333333	16.66665
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.333333	16.66665
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.333333	16.66665
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.333333	16.66665
IMMUNODEFICIENCY 46; IMD46	0.333333	16.66665
DANDY-WALKER SYNDROME	0.333333	16.66665
PARAGANGLIOMAS 1	0.333333	16.66665
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.33135121200000006	16.567560600000004
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.328077782	16.4038891
TUBEROUS SCLEROSIS	0.32591575100000003	16.29578755
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.31636785100000003	15.818392550000002
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.30439123300000004	15.219561650000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.293584882	14.6792441
GLUTAMINE DEFICIENCY, CONGENITAL	0.28655128100000005	14.327564050000003
#602398 DESMOSTEROLOSIS	0.285309733	14.26548665
MYASTHENIA GRAVIS; MG	0.2833333	14.166665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.280922712	14.046135600000001
118900 CIRRHOSIS, FAMILIAL	0.2651515	13.257575
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	13.235294999999999
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.26093099200000003	13.046549600000002
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.25880188300000007	12.940094150000004
INFANTILE LIVER FAILURE SYNDROME 2	0.258162131	12.908106550000001
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.25568182	12.784091
Pontine tegmental cap dysplasia	0.25534386300000006	12.767193150000002
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.25449998100000004	12.724999050000003
CEPHALIN LIPIDOSIS	0.25408163	12.704081500000001
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.25175963300000004	12.587981650000001
LOWE OCULOCEREBRORENAL SYNDROME	0.250915751	12.545787550000002
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.250915751	12.545787550000002
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.250915751	12.545787550000002
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.5
#300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;XLTDA	0.25	12.5
#614379 COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD ;;C4B DEFICIENCY	0.25	12.5
PATENT DUCTUS VENOSUS	0.25	12.5
TUFTSIN DEFICIENCY	0.25	12.5
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	12.5
DYSTONIA 6, TORSION	0.25	12.5
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	12.5
HYPEREKPLEXIA 1; HKPX1	0.25	12.5
CEROID STORAGE DISEASE	0.25	12.5
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	12.5
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.25	12.5
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.25	12.5
HYPERPARATHYROIDISM 2	0.25	12.5
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	12.5
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	12.5
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.25	12.5
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	11.221404999999999
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	11.221404999999999
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.21955679	10.9778395
LATHOSTEROLOSIS	0.21758275100000002	10.879137550000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.211713482	10.5856741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.211713482	10.5856741
PHELAN-MCDERMID SYNDROME; PHMDS	0.20880413299999998	10.440206649999999
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.206044251	10.30221255
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.20534386300000002	10.26719315
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.20175963300000002	10.087981650000001
COHEN SYNDROME	0.200915751	10.04578755
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.200915751	10.04578755
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.200843882	10.0421941
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.200843882	10.0421941
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.2	10.0
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.2	10.0
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.199328351	9.96641755
ADAMS-OLIVER SYNDROME 1; AOS1	0.198421383	9.921069150000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.194414082	9.720704099999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.190895181	9.54475905
PEHO-LIKE SYNDROME; PEHOL	0.189963012	9.498150599999999
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.18876984300000005	9.438492150000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.186928953	9.34644765
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.18266586	9.133293
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	9.1071691
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	9.064975
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.179920933	8.99604665
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.17718611999999997	8.859305999999998
NIEMANN-PICK DISEASE, TYPE C2	0.17283192300000003	8.641596150000002
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.17283192300000003	8.641596150000002
CHROMOSOME 1P36 DELETION SYNDROME	0.17213621299999998	8.60681065
PEHO SYNDROME; PEHO	0.17201086299999999	8.60054315
PYRUVATE CARBOXYLASE DEFICIENCY	0.168426633	8.421331649999999
GLUTARIC ACIDEMIA I; GA1	0.167582751	8.37913755
COFFIN-SIRIS SYNDROME 6; CSS6	0.167510882	8.3755441
#613112 MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	0.166667	8.333350000000001
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.166667	8.333350000000001
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.166667	8.333350000000001
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.166667	8.333350000000001
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.166667	8.333350000000001
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.15724438200000002	7.862219100000001
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.15286817200000002	7.643408600000001
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.14852299	7.426149499999999
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.14523139000000002	7.261569500000001
GLYCEROL KINASE DEFICIENCY; GKD	0.144616633	7.23083165
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	7.185044099999999
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1433483	7.167415000000001
DUBOWITZ SYNDROME	0.14285699999999998	7.142849999999999
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.141755841	7.08779205
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.1405258	7.02629
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.140297712	7.0148855999999995
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.14006922000000002	7.0034610000000015
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.13952911199999998	6.9764555999999995
219400 CYANOSIS AND HEPATIC DISEASE	0.1357143	6.785715000000001
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	6.7212250000000004
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.13423833300000002	6.711916650000001
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.133351982	6.6675991
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.133287781	6.66438905
COFFIN-SIRIS SYNDROME 2; CSS2	0.130717933	6.535896650000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.130041951	6.502097549999999
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.129997381	6.49986905
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.12918032000000002	6.459016000000001
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	6.29578755
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	6.287195
MUCOLIPIDOSIS IV; ML4	0.11989148200000002	5.994574100000001
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.119875613	5.993780650000001
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.11955679000000001	5.977839500000001
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.11864273300000003	5.932136650000001
COFFIN-SIRIS SYNDROME 4; CSS4	0.117384633	5.86923165
COFFIN-SIRIS SYNDROME 3; CSS3	0.117384633	5.86923165
TRICHOHEPATOENTERIC SYNDROME 2	0.1151515	5.757575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.11307080000000001	5.6535400000000005
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.11193296300000002	5.596648150000001
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.11184674300000001	5.5923371500000005
COACH SYNDROME	0.11145244300000001	5.572622150000001
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.10818720000000001	5.40936
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	5.405435
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.10750485100000001	5.37524255
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.106904482	5.345224099999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.10652570200000001	5.326285100000001
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.10568182000000001	5.284091
WHITE-SUTTON SYNDROME; WHSUS	0.104428112	5.2214056
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.10440529000000001	5.220264500000001
EVEN-PLUS SYNDROME	0.10271373200000002	5.1356866000000005
WITTEVEEN-KOLK SYNDROME	0.10201046300000001	5.100523150000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.10091575100000001	5.045787550000001
IMMUNODEFICIENCY 37; IMD37	0.10091575100000001	5.045787550000001
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.10091575100000001	5.045787550000001
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	5.045787550000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.10091575100000001	5.045787550000001
TARP SYNDROME; TARPS	0.10084388200000001	5.042194100000001
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.10084388200000001	5.042194100000001
JOUBERT SYNDROME 7	0.10084388200000001	5.042194100000001
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.10084388200000001	5.042194100000001
JOUBERT SYNDROME 2	0.10084388200000001	5.042194100000001
KRABBE DISEASE	0.100073931	5.00369655
PANENCEPHALITIS, SUBACUTE SCLEROSING	0.1	5.0
DYSTONIA, JUVENILE-ONSET	0.1	5.0
HEPATITIS B VACCINE, RESPONSE TO	0.1	5.0
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.1	5.0
#613783 COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD;;C1s DEFICIENCY	0.1	5.0
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	5.0
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	5.0
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	5.0
SECKEL SYNDROME 2; SCKL2	0.1	5.0
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	5.0
MEIER-GORLIN SYNDROME 5; MGORS5	0.1	5.0
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.1	5.0
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.1	5.0
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.09900185100000002	4.950092550000001
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.09771182	4.885591
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	4.8317441
SITOSTEROLEMIA	0.09531439000000001	4.7657195
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.09499073000000001	4.7495365000000005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.09424668200000001	4.7123341000000005
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.09409702100000002	4.704851050000001
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.0920746	4.6037300000000005
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.09182485100000001	4.5912425500000005
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.09157515100000001	4.578757550000001
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.09129130100000002	4.564565050000001
RCAD (renal cysts and diabetes)	0.0909091	4.5454550000000005
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0909091	4.5454550000000005
FIBROSCLEROSIS, MULTIFOCAL	0.0909091	4.5454550000000005
ATRANSFERRINEMIA	0.0909091	4.5454550000000005
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.0909091	4.5454550000000005
HEART AND BRAIN MALFORMATION SYNDROME	0.090105763	4.50528815
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	4.44079
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.08867716300000002	4.433858150000001
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.08867716300000002	4.433858150000001
RHEUMATOID ARTHRITIS	0.08791550000000001	4.395775
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.08701021000000002	4.350510500000001
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.08691753	4.3458765
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.08559865100000001	4.279932550000001
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.08509293300000002	4.2546466500000015
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.08509293300000002	4.2546466500000015
CAROLI DISEASE, ISOLATED	0.08427718	4.213858999999999
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.08417718200000002	4.208859100000001
JOUBERT SYNDROME 23; JBTS23	0.08417718200000002	4.208859100000001
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.08417718200000002	4.208859100000001
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.08417718200000002	4.208859100000001
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.08372582	4.186291000000001
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.08372582	4.186291000000001
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.08333330000000001	4.166665000000001
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.08333330000000001	4.166665000000001
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.08260492000000001	4.1302460000000005
YUNIS-VARON SYNDROME	0.08159515	4.0797575
NIEMANN-PICK DISEASE, TYPE B	0.08132839000000001	4.0664195
TANGIER DISEASE; TGD	0.08132839000000001	4.0664195
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.080440112	4.0220056
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.079832	3.9916
LISSENCEPHALY, X-LINKED, 2	0.079820401	3.99102005
COFFIN-SIRIS SYNDROME 1; CSS1	0.079756663	3.98783315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.07971867099999999	3.9859335499999995
ACROCALLOSAL SYNDROME; ACLS	0.079386601	3.96933005
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.07895830000000001	3.9479150000000005
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.07886889999999999	3.9434449999999996
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.078688741	3.9344370500000005
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.07837063	3.9185315
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	3.90625
LISSENCEPHALY 2; LIS2	0.07776698200000001	3.8883491000000006
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	3.8461550000000004
FISH-EYE DISEASE	0.07692310000000001	3.8461550000000004
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.07692310000000001	3.8461550000000004
CANAVAN DISEASE	0.07692310000000001	3.8461550000000004
ATHEROSCLEROSIS SUSCEPTIBILITY	0.07692310000000001	3.8461550000000004
HYPERLIPOPROTEINEMIA, TYPE V	0.07692310000000001	3.8461550000000004
MCLEOD SYNDROME; MCLDS	0.07692310000000001	3.8461550000000004
MYOCLONUS AND ATAXIA	0.07692310000000001	3.8461550000000004
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.07692310000000001	3.8461550000000004
MICROHYDRANENCEPHALY; MHAC	0.07529885	3.7649425
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.074838182	3.7419091
LISSENCEPHALY 5; LIS5	0.074652351	3.7326175500000005
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	3.721175
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	3.721175
Polyarteritis nodosa, childhood-onset	0.07353291	3.6766455000000002
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.07318823300000002	3.659411650000001
MYELOPEROXIDASE DEFICIENCY	0.07312923000000002	3.6564615000000007
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0728901	3.644505
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.07234435100000002	3.617217550000001
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.07234435100000002	3.617217550000001
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.07227248200000001	3.6136241000000004
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.07186239999999999	3.59312
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.07142860000000001	3.5714300000000003
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.07142860000000001	3.5714300000000003
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.07142860000000001	3.5714300000000003
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.071082483	3.5541241500000003
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.070932631	3.54663155
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	3.513075
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	3.513075
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.069952081	3.49760405
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.069384212	3.4692106000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.068845063	3.44225315
WILLIAMS-BEUREN SYNDROME; WBS	0.06775502	3.3877509999999997
SCLEROSING CHOLANGITIS, NEONATAL	0.06717579000000001	3.3587895000000008
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.06690529	3.3452645000000003
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.06690529	3.3452645000000003
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.06690529	3.3452645000000003
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.06690529	3.3452645000000003
OGDEN SYNDROME; OGDNS	0.066468882	3.3234441000000006
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.066468882	3.3234441000000006
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.0660173	3.300865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.065803051	3.29015255
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.065092933	3.25464665
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.06453013300000002	3.226506650000001
KABUKI SYNDROME 1	0.06425963300000001	3.2129816500000006
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.06424905100000002	3.212452550000001
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.064177182	3.2088590999999997
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	3.20815
Growth hormone deficiency, isolated, type IA	0.0636363	3.1818150000000003
#154780 MARSHALL SYNDROME; MRSHS	0.06333330000000001	3.1666650000000005
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.06333330000000001	3.1666650000000005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.063253933	3.16269665
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	3.1621949999999996
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	3.1621949999999996
GLYCOGEN STORAGE DISEASE IV	0.0627705	3.1385250000000005
MENTAL RETARDATION, X-LINKED 98; MRX98	0.062568333	3.12841665
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0625	3.125
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.0625	3.125
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.0625	3.125
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.0625	3.125
IMMUNODEFICIENCY 62; IMD62	0.0625	3.125
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.0625	3.125
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0625	3.125
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0610795	3.053975
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.060547433	3.02737165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.060073053	3.0036526500000003
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	2.9944800000000003
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.059703551	2.98517755
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.059451933	2.97259665
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.059139830000000004	2.9569915
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.05882701	2.9413505
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.058608051	2.93040255
CYCLIC NEUTROPENIA	0.058184200000000005	2.9092100000000003
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	2.86647
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.057209731	2.86048655
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.057131581	2.85657905
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	2.832335
NAVAJO NEUROHEPATOPATHY	0.056575062	2.8287531
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	2.8199741
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.056232092	2.8116046
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.055710112000000006	2.7855056000000005
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	2.7777800000000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	2.7777800000000004
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	2.7777800000000004
CHROMOSOME 17q12 DELETION SYNDROME	0.055555600000000004	2.7777800000000004
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	2.7777800000000004
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	2.7777800000000004
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.055343863	2.76719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.055343863	2.76719315
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.054961913	2.7480956500000002
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.054864882000000004	2.7432441
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.054825490000000004	2.7412745000000003
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.054582200000000004	2.7291100000000004
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0545058	2.72529
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.0545058	2.72529
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.054391233	2.7195616499999997
EPILEPSY, PYRIDOXINE-DEPENDENT	0.054124312	2.7062156
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.053906363	2.69531815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.053654282	2.6827141
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0535793	2.6789650000000003
YOU-HOOVER-FONG SYNDROME; YHFS	0.053475482	2.6737740999999997
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.0526316	2.63158
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.052232631	2.6116315500000002
HARDIKAR SYNDROME	0.05202429	2.6012145
PORTAL HYPERTENSION, NONCIRRHOTIC	0.05202429	2.6012145
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.051701682	2.5850841
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.050798363	2.53991815
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.05072468000000001	2.5362340000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.050415482	2.5207740999999997
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	2.51488165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.050246851	2.51234255
NASODIGITOACOUSTIC SYNDROME	0.05	2.5
KEIPERT SYNDROME; KPTS	0.05	2.5
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.05	2.5
DIAMOND-BLACKFAN ANEMIA 8	0.05	2.5
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.05	2.5
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.05	2.5
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.04908798	2.454399
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.04903873	2.4519365
STUVE-WIEDEMANN SYNDROME	0.049019599999999997	2.45098
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	2.4269
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	2.4269
RAGWEED SENSITIVITY	0.048039200000000004	2.4019600000000003
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.048039200000000004	2.4019600000000003
ADAMS-OLIVER SYNDROME 6; AOS6	0.047619	2.38095
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.047619	2.38095
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.047619	2.38095
#604901 NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC	0.047619	2.38095
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.047619	2.38095
#615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	0.047619	2.38095
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.047263383	2.36316915
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.047214133000000005	2.3607066500000005
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.047214133000000005	2.3607066500000005
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.047214133000000005	2.3607066500000005
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.046732281	2.33661405
HYPOADRENOCORTICISM, FAMILIAL	0.046623631000000006	2.33118155
SMITH-MAGENIS SYNDROME; SMS	0.046587233000000006	2.32936165
LYSOSOMAL ACID LIPASE DEFICIENCY	0.046410969999999996	2.3205484999999997
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.046370251	2.31851255
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.046370251	2.31851255
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.046321882	2.3160941
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.046298382	2.3149191
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.046298382	2.3149191
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.046298382	2.3149191
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.046074212	2.3037106
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.0454545	2.272725
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.0454545	2.272725
GABRIELE-DE VRIES SYNDROME; GADEVS	0.045427181999999997	2.2713590999999997
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0453011	2.265055
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.045287282	2.2643641
MARSHALL-SMITH SYNDROME; MRSHSS	0.04494707	2.2473535
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.044914382	2.2457191
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.044638653	2.23193265
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.044322182	2.2161091
GOLDBERG-SHPRINTZEN SYNDROME	0.044205212	2.2102606000000002
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.043805363	2.19026815
POTOCKI-LUPSKI SYNDROME	0.043805363	2.19026815
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.043710672	2.1855336
LIP, MEDIAN NODULE OF UPPER	0.043478300000000004	2.173915
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.043478300000000004	2.173915
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.043478300000000004	2.173915
BLEPHAROCHALASIS AND DOUBLE LIP	0.043478300000000004	2.173915
SHPRINTZEN OMPHALOCELE SYNDROME	0.043478300000000004	2.173915
BAZEX SYNDROME; BZX	0.043478300000000004	2.173915
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.043478300000000004	2.173915
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.043478300000000004	2.173915
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.043478300000000004	2.173915
MAL DE MELEDA	0.043478300000000004	2.173915
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.043478300000000004	2.173915
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.043478300000000004	2.173915
LIP, HAMARTOMATOUS	0.043478300000000004	2.173915
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.043478300000000004	2.173915
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0434609	2.1730449999999997
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.043401882	2.1700941
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.042961481	2.14807405
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.042889612	2.1444806
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.042889612	2.1444806
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.042756550000000004	2.1378275
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.04251702	2.125851
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.042477771	2.1238885499999998
HURLER-SCHEIE SYNDROME	0.04219489	2.1097445
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.042194881999999996	2.1097441
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.04204573	2.1022865
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.041960302000000005	2.0980151000000005
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.0932790999999997
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	2.0932790999999997
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.041717913	2.0858956500000003
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.041664062	2.0832031
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.041648411999999996	2.0824206
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.04131735	2.0658675
CIRRHOSIS, FAMILIAL	0.04111642	2.055821
HALLERMANN-STREIFF SYNDROME; HSS	0.04111642	2.055821
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.051085
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.040221133	2.01105665
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.040009301	2.00046505
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.03979593000000001	1.9897965000000004
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.03979593000000001	1.9897965000000004
MACROCYTOSIS, FAMILIAL	0.03979593000000001	1.9897965000000004
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.03979593000000001	1.9897965000000004
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.03979593000000001	1.9897965000000004
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.03979593000000001	1.9897965000000004
FLOOD FACTOR DEFICIENCY	0.03979593000000001	1.9897965000000004
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.03979593000000001	1.9897965000000004
COUMARIN RESISTANCE	0.03979593000000001	1.9897965000000004
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.03949891	1.9749455
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.039377251	1.96886255
COWDEN SYNDROME 6; CWS6	0.039377251	1.96886255
COWDEN SYNDROME 5; CWS5	0.039377251	1.96886255
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.039305382	1.9652691
SILVER-RUSSELL SYNDROME; SRS	0.039305382	1.9652691
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.039305382	1.9652691
ACROMICRIC DYSPLASIA	0.0390593	1.9529649999999998
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.038979933	1.94899665
CORNELIA DE LANGE SYNDROME 3	0.038979933	1.94899665
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.038877451	1.94387255
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0384757	1.923785
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.923075
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	1.923075
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0384615	1.923075
WATSON SYNDROME	0.0384615	1.923075
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.923075
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.923075
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0384615	1.923075
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.923075
THUMB DEFORMITY	0.0384615	1.923075
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.923075
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.923075
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.923075
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.923075
BETHLEM MYOPATHY 1	0.0384615	1.923075
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.923075
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0384615	1.923075
ACRORENAL-MANDIBULAR SYNDROME	0.0384615	1.923075
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0384615	1.923075
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0384615	1.923075
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.923075
ARTERIES, ANOMALIES OF	0.0384615	1.923075
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.037835933	1.89179665
GITELMAN SYNDROME	0.037573931	1.87869655
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.037414930000000006	1.8707465000000003
BLOOD GROUP, DUFFY SYSTEM; FY	0.037414930000000006	1.8707465000000003
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.037414930000000006	1.8707465000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.037395163	1.86975815
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.037248712	1.8624356000000002
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.037084683	1.85423415
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.036992051	1.84960255
MYELOCEREBELLAR DISORDER	0.03693182	1.8465909999999999
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	1.8464049999999999
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	1.8464049999999999
TRANSALDOLASE DEFICIENCY	0.03673291	1.8366455
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.03665818	1.832909
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.036630051000000004	1.8315025500000002
GAUCHER DISEASE, TYPE I	0.036497629999999996	1.8248814999999998
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.03621452	1.810726
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.035885033	1.7942516499999999
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.035771620000000004	1.7885810000000002
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.035714300000000004	1.7857150000000002
HEMOPOIETIC PROLIFERATION	0.035714300000000004	1.7857150000000002
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.035714300000000004	1.7857150000000002
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.035714300000000004	1.7857150000000002
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.035714300000000004	1.7857150000000002
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.7857150000000002
SULFHEMOGLOBINEMIA, CONGENITAL	0.035714300000000004	1.7857150000000002
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.7857150000000002
GASTRIC SNEEZING	0.035714300000000004	1.7857150000000002
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.7857150000000002
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.035714300000000004	1.7857150000000002
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.7857150000000002
GIANT NEUTROPHIL LEUKOCYTES	0.035714300000000004	1.7857150000000002
METHANE PRODUCTION	0.035714300000000004	1.7857150000000002
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.035714300000000004	1.7857150000000002
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.7857150000000002
EOSINOPHILOPENIA	0.035714300000000004	1.7857150000000002
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.035714300000000004	1.7857150000000002
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.7857150000000002
MYELOMA, MULTIPLE	0.035714300000000004	1.7857150000000002
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.7857150000000002
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.7857150000000002
TERATOMA, PINEAL	0.035714300000000004	1.7857150000000002
ACETOPHENETIDIN SENSITIVITY	0.035714300000000004	1.7857150000000002
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.7857150000000002
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	1.7857150000000002
BLUE DIAPER SYNDROME	0.035714300000000004	1.7857150000000002
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.035714300000000004	1.7857150000000002
CHANARIN-DORFMAN SYNDROME	0.035714300000000004	1.7857150000000002
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.035714300000000004	1.7857150000000002
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03533163	1.7665815
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.03509362	1.754681
IMMUNODEFICIENCY 10; IMD10	0.03509362	1.754681
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.03509293300000001	1.7546466500000004
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.0347593	1.737965
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.03473619	1.7368095000000001
FONTAINE PROGEROID SYNDROME; FPS	0.03468633	1.7343165
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.034647332999999995	1.7323666499999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.034395262999999995	1.7197631499999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.034395262999999995	1.7197631499999997
COFFIN-SIRIS SYNDROME 5	0.034302163	1.7151081499999998
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.034296652	1.7148325999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.034165612	1.7082806
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.034165612	1.7082806
FAMILIAL MEDITERRANEAN FEVER; FMF	0.03381709	1.6908545000000001
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.03381709	1.6908545000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0338068	1.69034
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.033789363	1.6894681500000002
CORNELIA DE LANGE SYNDROME 1	0.033716870999999995	1.6858435499999997
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.033626663	1.68133315
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	1.67869
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.033344051000000006	1.6672025500000003
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	1.666665
SHORT SYNDROME	0.0333333	1.666665
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	1.666665
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	1.666665
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	1.666665
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0333333	1.666665
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	1.666665
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	1.666665
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	1.666665
IMMUNE SUPPRESSION	0.0333333	1.666665
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	1.666665
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	1.666665
ECHO VIRUS 11 SENSITIVITY	0.0333333	1.666665
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	1.666665
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0333333	1.666665
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	1.666665
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	1.666665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.03332173	1.6660865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.03332173	1.6660865
LETTERER-SIWE DISEASE	0.03320822	1.6604109999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.033091800000000005	1.6545900000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.033009633	1.65048165
LISSENCEPHALY 1; LIS1	0.033009633	1.65048165
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.033009633	1.65048165
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.033009633	1.65048165
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0328877	1.644385
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.032873612	1.6436806000000002
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.032841502	1.6420751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.032532282	1.6266141
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.032532282	1.6266141
ZUNICH NEUROECTODERMAL SYNDROME	0.032430851	1.6215425499999998
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.0323232	1.6161600000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.032261813	1.61309065
MEGALENCEPHALY WITH DYSMYELINATION	0.032165751	1.60828755
OCULODENTODIGITAL DYSPLASIA; ODDD	0.032165751	1.60828755
METACHROMATIC LEUKODYSTROPHY	0.032165751	1.60828755
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.032165751	1.60828755
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.032165751	1.60828755
Adrenoleukodystrophy	0.032165751	1.60828755
CHROMOSOME 18Q DELETION SYNDROME	0.032165751	1.60828755
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.032093882	1.6046941
PEROXISOME BIOGENESIS DISORDER 6B	0.032093882	1.6046941
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.032093882	1.6046941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.031954512000000004	1.5977256000000002
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.031619281	1.58096405
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.031254013	1.5627006499999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.03125	1.5625
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.03125	1.5625
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.03125	1.5625
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.03125	1.5625
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.03125	1.5625
MENKES DISEASE	0.031218750999999996	1.5609375499999998
15q13.3 microdeletion syndrome	0.031218750999999996	1.5609375499999998
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	1.5609375499999998
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.031171433	1.55857165
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.031171433	1.55857165
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.031171433	1.55857165
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.031171433	1.55857165
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031146881999999997	1.5573441
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031146881999999997	1.5573441
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.03070353	1.5351765
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.030591850999999996	1.5295925499999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.030581382	1.5290691
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.030581382	1.5290691
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.030581382	1.5290691
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.030581382	1.5290691
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.030538792000000002	1.5269396000000002
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.516545
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.516545
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.516545
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.030327550999999998	1.5163775499999999
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.5151499999999998
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.030302999999999997	1.5151499999999998
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.5151499999999998
15q24 recurrent microdeletion syndrome	0.030302999999999997	1.5151499999999998
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.5151499999999998
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.5151499999999998
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.5151499999999998
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.5151499999999998
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	1.5151499999999998
22q11.2 distal deletion syndrome	0.030302999999999997	1.5151499999999998
CLEFT CHIN	0.030302999999999997	1.5151499999999998
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	1.5151499999999998
DIMPLES, FACIAL	0.030302999999999997	1.5151499999999998
OROFACIAL CLEFT 3	0.030302999999999997	1.5151499999999998
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.5151499999999998
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	1.5151499999999998
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.5151499999999998
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.5151499999999998
NASAL BONES, ABSENCE OF	0.030302999999999997	1.5151499999999998
DWARFISM, LEVI TYPE	0.030302999999999997	1.5151499999999998
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.5151499999999998
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	1.5151499999999998
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.5151499999999998
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.5151499999999998
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.030255682	1.5127841
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.030233661	1.51168305
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.030175682	1.5087841
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.030148640999999997	1.5074320499999998
ZIMMERMANN-LABAND SYNDROME 1	0.030148640999999997	1.5074320499999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0301004	1.50502
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.029967150999999997	1.49835755
COFFIN-SIRIS SYNDROME 8; CSS8	0.029874051	1.4937025499999999
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.029853371	1.49266855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0297375	1.486875
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.029676099999999997	1.4838049999999998
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0296741	1.4837049999999998
MARSILI SYNDROME; MARSIS	0.0294118	1.4705899999999998
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0294118	1.4705899999999998
DOHLE BODIES AND LEUKEMIA	0.0294118	1.4705899999999998
MAJEED SYNDROME	0.0294118	1.4705899999999998
Yao syndrome	0.0294118	1.4705899999999998
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.0294118	1.4705899999999998
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
IMMUNODEFICIENCY 9; IMD9	0.0294118	1.4705899999999998
IMMUNODEFICIENCY 61; IMD61	0.0294118	1.4705899999999998
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0294118	1.4705899999999998
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.029327581	1.46637905
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.029289382000000003	1.4644691
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.029286033	1.46430165
MEIER-GORLIN SYNDROME 1; MGORS1	0.0289583	1.447915
WIEDEMANN-STEINER SYNDROME; WDSTS	0.028878933	1.44394665
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.028878933	1.44394665
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.028878933	1.44394665
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.028442151	1.42210755
PRIMROSE SYNDROME; PRIMS	0.02841183	1.4205915
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.028282799999999997	1.4141399999999997
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.028106191	1.40530955
ALAZAMI-YUAN SYNDROME	0.027963182	1.3981591
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.027934281	1.39671405
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.027755781	1.38778905
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.027755781	1.38778905
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.027755781	1.38778905
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.027493932000000002	1.3746966
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.027338482	1.3669241
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.027338482	1.3669241
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.027254402	1.3627201
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.027254402	1.3627201
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.027254402	1.3627201
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.3579841000000001
HAREL-YOON SYNDROME; HAYOS	0.027159682	1.3579841000000001
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.0271193	1.3559649999999999
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.0271193	1.3559649999999999
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.027044081999999997	1.3522040999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.026939163000000002	1.34695815
DESANTO-SHINAWI SYNDROME	0.026939163000000002	1.34695815
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.02684003	1.3420015
FUMARASE DEFICIENCY; FMRD	0.026754032	1.3377016
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.026641750999999998	1.33208755
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.026552643	1.3276321500000001
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.0264946	1.32473
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.0264946	1.32473
ROWLEY-ROSENBERG SYNDROME	0.02641052	1.320526
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.02641052	1.320526
#178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1;;PHT;;PULMONARY ARTERIAL HYPERTENSION; PAHPULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA,INCLUDED;;PPH1 WITH HHT, INCLUDED	0.02641052	1.320526
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02641052	1.320526
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.02641052	1.320526
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.02641052	1.320526
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.02641052	1.320526
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.31579
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.31579
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.31579
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.026133502000000003	1.3066751
POPOV-CHANG SYNDROME; POPCHAS	0.025828401999999997	1.2914200999999998
KAGAMI-OGATA SYNDROME	0.025772723	1.28863615
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.02571211	1.2856055
ELSAHY-WATERS SYNDROME; ESWS	0.025671482	1.2835741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.025449733000000002	1.27248665
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.025289620000000002	1.2644810000000002
SEA-BLUE HISTIOCYTE DISEASE	0.025238609999999998	1.2619304999999998
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.025193933	1.25969665
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.025193933	1.25969665
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.025072063	1.25360315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.025050493	1.25252465
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.025015433	1.25077165
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.025015433	1.25077165
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.025015433	1.25077165
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.025015433	1.25077165
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.024951663000000002	1.24758315
ADAMS-OLIVER SYNDROME 5; AOS5	0.024928841	1.24644205
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0248276	1.24138
WEBB-DATTANI SYNDROME; WEDAS	0.024574663	1.22873315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.024574663	1.22873315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.024551840999999998	1.22759205
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.024479972	1.2239986
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.024336161	1.21680805
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.024228180999999998	1.2114090499999999
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.024171551	1.20857755
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.024171551	1.20857755
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.024171551	1.20857755
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.024171551	1.20857755
CITRULLINEMIA, CLASSIC	0.024157513	1.2078756499999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.024123533	1.20617665
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.024099682	1.2049841000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.024099682	1.2049841000000001
OPTIC ATROPHY 11; OPA11	0.024099682	1.2049841000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.024056770999999998	1.2028385499999998
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.024035912000000003	1.2017956
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.023981833	1.19909165
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.023730781	1.18653905
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.023730781	1.18653905
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.023730781	1.18653905
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.023730781	1.18653905
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.023711912999999998	1.1855956499999998
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.023711912999999998	1.1855956499999998
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.02368943	1.1844715000000001
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.023583001	1.17915005
XQ25 DUPLICATION SYNDROME	0.023525663	1.17628315
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.023434299999999998	1.1717149999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.023434299999999998	1.1717149999999998
HURLER SYNDROME	0.023430971999999998	1.1715486
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.023313630999999998	1.16568155
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.023296012	1.1648006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.023296012	1.1648006
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.023296011999999998	1.1648006
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.02327319	1.1636595
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0232558	1.16279
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0232558	1.16279
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.0232558	1.16279
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0232558	1.16279
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.0232558	1.16279
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0232558	1.16279
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.023066082	1.1533041000000002
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.1533041000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.1533041000000002
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.023066082	1.1533041000000002
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	1.1474765
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	1.1474765
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02294953	1.1474765
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	1.1474765
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	1.1474765
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	1.1474765
HYPOPHOSPHATASIA, INFANTILE	0.022868030999999997	1.1434015499999999
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.022868030999999997	1.1434015499999999
WARBURG MICRO SYNDROME 2; WARBM2	0.02281503	1.1407515
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.022681780999999998	1.1340890499999998
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.022681780999999998	1.1340890499999998
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.022681780999999998	1.1340890499999998
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.02258554	1.129277
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.02253602	1.126801
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.022424371	1.12121855
GALACTOSEMIA	0.02239788	1.119894
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.02239788	1.119894
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.022263429999999997	1.1131714999999998
EPILEPSY, HOT WATER, 1	0.0222222	1.11111
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.11111
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.11111
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.11111
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.11111
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.11111
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.021952279999999998	1.0976139999999999
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.021740852999999997	1.0870426499999999
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.021677202	1.0838600999999999
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.02150862	1.075431
STIFF-PERSON SYNDROME; SPS	0.02150862	1.075431
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.021316422999999998	1.0658211499999999
PELGER-HUET ANOMALY; PHA	0.021231602	1.0615801
ADENYLOSUCCINASE DEFICIENCY	0.020990433	1.04952165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.020990433	1.04952165
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.020990433	1.04952165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.020968863	1.04844315
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.020968863	1.04844315
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.020968863	1.04844315
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.020968863	1.04844315
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.020968863	1.04844315
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.02083332	1.041666
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.02083332	1.041666
GLYCINE ENCEPHALOPATHY; GCE	0.020778501	1.03892505
HYPERPROLINEMIA, TYPE I	0.020627533	1.03137665
HYPERCALCEMIA, INFANTILE, 1	0.02057968	1.028984
IMMUNODEFICIENCY 47	0.020472540999999997	1.0236270499999998
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.020387719999999998	1.019386
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.020387719999999998	1.019386
#256520 NEU-LAXOVA SYNDROME; NLS	0.02037555	1.0187775
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.020296183	1.01480915
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.020146551	1.0073275499999998
SECKEL SYNDROME 7; SCKL7	0.020146551	1.0073275499999998
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.020146551	1.0073275499999998
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.020146551	1.0073275499999998
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.020146551	1.0073275499999998
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.020146551	1.0073275499999998
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.020146551	1.0073275499999998
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.020074682	1.0037341
300270 ADRENOMYODYSTROPHY	0.020074682	1.0037341
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.020066880000000002	1.003344
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.020053112	1.0026556
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.020053111999999998	1.0026556
PETTIGREW SYNDROME	0.019941432999999998	0.9970716499999999
TEMPLE-BARAITSER SYNDROME; TMBTS	0.019941432999999998	0.9970716499999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.019941432999999998	0.9970716499999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.019941432999999998	0.9970716499999999
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.019941432999999998	0.9970716499999999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.019941432999999998	0.9970716499999999
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.019875613	0.99378065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.019711782	0.9855891
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	0.9855891
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	0.9855891
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	0.9855891
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.019711782	0.9855891
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	0.9855891
RING CHROMOSOME 14 SYNDROME	0.019711782	0.9855891
#234810 PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2;;HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY	0.0196078	0.9803900000000001
CARDIOMYOPATHY, DILATED, 2C; CMD2C	0.0196078	0.9803900000000001
PULMONARY HYPERTENSION, PRIMARY, 4	0.0196078	0.9803900000000001
#614475 ATRIAL SEPTAL DEFECT 9; ASD9	0.0196078	0.9803900000000001
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0196078	0.9803900000000001
#615343 PULMONARY HYPERTENSION, PRIMARY, 3; PPH3	0.0196078	0.9803900000000001
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0196078	0.9803900000000001
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.0196078	0.9803900000000001
#615342 PULMONARY HYPERTENSION, PRIMARY, 2; PPH2	0.0196078	0.9803900000000001
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.0196078	0.9803900000000001
PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT	0.0196078	0.9803900000000001
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.0196078	0.9803900000000001
MELNICK-NEEDLES SYNDROME	0.0196078	0.9803900000000001
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.0196078	0.9803900000000001
TYROSINEMIA, TYPE I; TYRSN1	0.019556789999999998	0.9778394999999999
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.019556789999999998	0.9778394999999999
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.019556789999999998	0.9778394999999999
GLYCOGEN STORAGE DISEASE IXC	0.019556789999999998	0.9778394999999999
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.019556789999999998	0.9778394999999999
HEMOCHROMATOSIS, TYPE 1	0.019556789999999998	0.9778394999999999
HEMOCHROMATOSIS, TYPE 2B	0.019556789999999998	0.9778394999999999
Lipodystrophy, congenital generalized, type 1	0.019556789999999998	0.9778394999999999
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.019556789999999998	0.9778394999999999
HEMOCHROMATOSIS, TYPE 2A	0.019556789999999998	0.9778394999999999
Lipodystrophy, congenital generalized, type 2	0.019556789999999998	0.9778394999999999
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.019556789999999998	0.9778394999999999
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.01952679	0.9763394999999999
HOLOPROSENCEPHALY 11	0.019380432	0.9690215999999999
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0192308	0.96154
ALLAN-HERNDON-DUDLEY SYNDROME	0.0192308	0.96154
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0192308	0.96154
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.01920923	0.9604615000000001
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01920923	0.9604615000000001
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.019174563	0.9587281499999999
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.01911119	0.9555595
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.01911119	0.9555595
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.01911119	0.9555595
IMMUNODEFICIENCY 32B; IMD32B	0.01911119	0.9555595
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.01911119	0.9555595
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.01911119	0.9555595
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.01911119	0.9555595
GLYCOGEN STORAGE DISEASE II	0.01911119	0.9555595
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01911119	0.9555595
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.01911119	0.9555595
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.019107013	0.95535065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.019107013	0.95535065
NOONAN SYNDROME 7; NS7	0.019097550999999997	0.9548775499999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.019025682	0.9512841
Retinitis pigmentosa with or without skeletal anomalies	0.019025682	0.9512841
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.019025682	0.9512841
JOUBERT SYNDROME 10	0.019025682	0.9512841
ALAZAMI SYNDROME; ALAZS	0.019025682	0.9512841
NOONAN SYNDROME 5; NS5	0.019025682	0.9512841
THAUVIN-ROBINET-FAIVRE SYNDROME	0.019025682	0.9512841
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.019025682	0.9512841
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.019025682	0.9512841
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.019025682	0.9512841
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.018902883000000002	0.9451441500000001
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.943395
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.943395
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.943395
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	0.943395
CARDIAC ARRHYTHMIA	0.0188679	0.943395
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.943395
269800 SENILE PLAQUE FORMATION	0.0188679	0.943395
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.943395
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.943395
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.943395
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0188679	0.943395
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.943395
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.943395
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.943395
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.943395
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	0.943395
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.943395
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.943395
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.943395
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.943395
ERYTHERMALGIA, PRIMARY	0.0188679	0.943395
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.943395
MOTION SICKNESS	0.0188679	0.943395
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.943395
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.943395
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.943395
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.943395
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.943395
PALMOMENTAL REFLEX	0.0188679	0.943395
THUMBS, CONGENITAL CLASPED	0.0188679	0.943395
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.943395
MYOPATHY, CONGENITAL	0.0188679	0.943395
ALCOHOL DEPENDENCE	0.0188679	0.943395
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.943395
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.943395
JUMPING FRENCHMAN OF MAINE	0.0188679	0.943395
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.943395
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.943395
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.943395
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.943395
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.943395
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.943395
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.943395
CERVICAL RIB	0.0188679	0.943395
DIASTEMATOMYELIA	0.0188679	0.943395
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01878753	0.9393765000000001
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.018654340999999998	0.9327170499999999
MUCOPOLYSACCHARIDOSIS, TYPE II	0.018654340999999998	0.9327170499999999
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.018502320000000003	0.9251160000000002
GAPO SYNDROME; GAPOS	0.018330680999999998	0.9165340499999999
ASPARTYLGLUCOSAMINURIA; AGU	0.018330680999999998	0.9165340499999999
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.018330680999999998	0.9165340499999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.018290129999999998	0.9145064999999999
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.018181799999999998	0.90909
CHITAYAT SYNDROME	0.018181799999999998	0.90909
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.018181799999999998	0.90909
MEIER-GORLIN SYNDROME 6; MGORS6	0.018181799999999998	0.90909
THREE M SYNDROME 2; 3M2	0.018181799999999998	0.90909
MEIER-GORLIN SYNDROME 8; MGORS8	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.018181799999999998	0.90909
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.018181799999999998	0.90909
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.018181799999999998	0.90909
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.018181799999999998	0.90909
FEINGOLD SYNDROME 1; FGLDS1	0.018181799999999998	0.90909
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.018164363000000003	0.9082181500000002
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.018164363000000003	0.9082181500000002
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.018164363000000003	0.9082181500000002
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.018059000999999998	0.90295005
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.018059000999999998	0.90295005
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.017987132000000003	0.8993566000000002
HADZISELIMOVIC SYNDROME	0.017761412	0.8880706
#300867 KABUKI SYNDROME 2; KABUK2	0.017384633	0.86923165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.017384633	0.86923165
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01733349	0.8666745
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.017320481000000002	0.8660240500000002
PITT-HOPKINS SYNDROME	0.017320481000000002	0.8660240500000002
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01714325	0.8571624999999999
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01691753	0.8458765
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.01691753	0.8458765
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.016911133	0.8455566499999999
AL KAISSI SYNDROME; ALKAS	0.016838163	0.84190815
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.016815340999999998	0.8407670499999998
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.016815340999999998	0.8407670499999998
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.016815340999999998	0.8407670499999998
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.016671873	0.83359365
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	0.82703755
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.016540751	0.82703755
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	0.82703755
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.016540751	0.82703755
EPILEPSY-TELANGIECTASIA	0.016491680999999998	0.8245840499999999
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	0.8234441
CHOPS SYNDROME; CHOPS	0.016468882	0.8234441
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.016468882	0.8234441
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.016468882	0.8234441
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.016468882	0.8234441
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	0.8234441
Mental retardation, autosomal dominant 21	0.016468882	0.8234441
ROIFMAN-CHITAYAT SYNDROME	0.016468882	0.8234441
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	0.8234441
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	0.8234441
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.016468882	0.8234441
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.016468882	0.8234441
HYPOTONIA-CYSTINURIA SYNDROME	0.016468882	0.8234441
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	0.8234441
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.016465532999999997	0.8232766499999998
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.016213463	0.8106731500000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.016213463	0.8106731500000001
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.016067250999999998	0.8033625499999999
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.015995382	0.7997690999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.015995382	0.7997690999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.015994281	0.79971405
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.015922412	0.7961206000000001
HYDROXYLYSINURIA	0.015625	0.78125
TRICHOMEGALY; TCMGLY	0.015625	0.78125
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.015625	0.78125
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	0.78125
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	0.78125
Oliver-McFarlane syndrome	0.015625	0.78125
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.015625	0.78125
PAINE SYNDROME	0.015625	0.78125
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	0.78125
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.015625	0.78125
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	0.78125
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.015625	0.78125
KENNERKNECHT SYNDROME	0.015625	0.78125
FLOATING-HARBOR SYNDROME	0.015625	0.78125
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.015625	0.78125
CARNOSINEMIA	0.015625	0.78125
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	0.78125
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	0.78125
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	0.78125
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.015625	0.78125
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.015625	0.78125
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.015621650999999999	0.7810825499999999
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.015621650999999999	0.7810825499999999
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.015621650999999999	0.7810825499999999
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	0.7810825499999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	0.7810825499999999
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	0.7774891
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	0.7774891
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	0.7774891
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.015444863	0.77224315
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.015444863	0.77224315
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.015444863	0.77224315
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.015444863	0.77224315
KOOLEN-DE VRIES SYNDROME; KDVS	0.015444863	0.77224315
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.015444863	0.77224315
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.015444863	0.77224315
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.015369581	0.76847905
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.015369581	0.76847905
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.015151499999999998	0.7575749999999999
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.015151499999999998	0.7575749999999999
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.015151499999999998	0.7575749999999999
PORPHYRIA CUTANEA TARDA	0.015151499999999998	0.7575749999999999
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.015151499999999998	0.7575749999999999
ALAGILLE SYNDROME 1; ALGS1	0.015151499999999998	0.7575749999999999
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.015151499999999998	0.7575749999999999
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.015151499999999998	0.7575749999999999
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.015151499999999998	0.7575749999999999
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.015151499999999998	0.7575749999999999
CRANIOECTODERMAL DYSPLASIA 3	0.015151499999999998	0.7575749999999999
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.015151499999999998	0.7575749999999999
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.015151499999999998	0.7575749999999999
HEMOCHROMATOSIS, NEONATAL	0.015151499999999998	0.7575749999999999
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.015151499999999998	0.7575749999999999
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.015151499999999998	0.7575749999999999
HEMOCHROMATOSIS, TYPE 3; HFE3	0.015151499999999998	0.7575749999999999
Helsmoortel-van der Aa syndrome	0.015092933	0.75464665
MENTAL RETARDATION, X-LINKED 9	0.015092933	0.75464665
RECOMBINANT CHROMOSOME 8 SYNDROME	0.015092933	0.75464665
#170100 PROLIDASE DEFICIENCY	0.015012622	0.7506311
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.014964851000000001	0.7482425500000001
Fabry disease	0.014964851000000001	0.7482425500000001
OROFACIODIGITAL SYNDROME I; OFD1	0.014760721000000001	0.73803605
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0147059	0.7352949999999999
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.0147059	0.7352949999999999
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.0147059	0.7352949999999999
FEVER, FAMILIAL LIFELONG PERSISTENT	0.0147059	0.7352949999999999
DYSTONIA 12; DYT12	0.0147059	0.7352949999999999
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.7352949999999999
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.0147059	0.7352949999999999
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.0147059	0.7352949999999999
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.7352949999999999
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.7352949999999999
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.0147059	0.7352949999999999
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.7352949999999999
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0147059	0.7352949999999999
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.7352949999999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.7352949999999999
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.7352949999999999
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0147059	0.7352949999999999
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.0147059	0.7352949999999999
PSORIASIS 14, PUSTULAR	0.0147059	0.7352949999999999
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.7352949999999999
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0147059	0.7352949999999999
CINCA SYNDROME; CINCA	0.0147059	0.7352949999999999
PSEUDODIASTROPHIC DYSPLASIA	0.0147059	0.7352949999999999
CAFFEY DISEASE	0.0147059	0.7352949999999999
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0147059	0.7352949999999999
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.0147059	0.7352949999999999
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0147059	0.7352949999999999
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.0147059	0.7352949999999999
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.7352949999999999
PANCREATITIS, HEREDITARY	0.0147059	0.7352949999999999
RHABDOMYOLYSIS, ACUTE RECURRENT	0.0147059	0.7352949999999999
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.0147059	0.7352949999999999
NEUROPATHY, PAINFUL	0.0147059	0.7352949999999999
METHYLMALONIC ACIDURIA, CBLA TYPE	0.014687833	0.7343916500000001
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.014687833	0.7343916500000001
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.014687833	0.7343916500000001
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.014600981	0.7300490500000001
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.014580133000000002	0.7290066500000001
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.014580133000000002	0.7290066500000001
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.014580133000000002	0.7290066500000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.014580133000000002	0.7290066500000001
HYPEREKPLEXIA 4; HKPX4	0.014580133000000002	0.7290066500000001
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.014580133000000002	0.7290066500000001
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.014580133000000002	0.7290066500000001
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.014580133000000002	0.7290066500000001
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.014580133000000002	0.7290066500000001
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.014580133000000002	0.7290066500000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.014580133000000002	0.7290066500000001
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.014580133000000002	0.7290066500000001
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.014580133000000002	0.7290066500000001
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.014580133000000002	0.7290066500000001
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.014529112	0.7264556
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.014529112	0.7264556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.01445383	0.7226915
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.014249050999999999	0.71245255
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.014249050999999999	0.71245255
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.014249050999999999	0.71245255
CLARK-BARAITSER SYNDROME	0.014249050999999999	0.71245255
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.014249050999999999	0.71245255
ATKIN-FLAITZ SYNDROME	0.014249050999999999	0.71245255
FOUNTAIN SYNDROME	0.014249050999999999	0.71245255
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.014182630000000002	0.7091315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.014177182	0.7088591
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.014177182	0.7088591
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.014177182	0.7088591
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.014177182	0.7088591
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.014177182	0.7088591
COSTELLO SYNDROME; CSTLO	0.014177182	0.7088591
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.014177182	0.7088591
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.0140491	0.702455
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.013843951	0.69219755
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.013772082	0.6886040999999999
METHYLMALONIC ACIDURIA, CBLB TYPE	0.013772082	0.6886040999999999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.013736251000000001	0.6868125500000001
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.013736251000000001	0.6868125500000001
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.013736251000000001	0.6868125500000001
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.013736251000000001	0.6868125500000001
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.013736251000000001	0.6868125500000001
CROME SYNDROME	0.013736251000000001	0.6868125500000001
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.013736251000000001	0.6868125500000001
CHROMOSOME 13q14 DELETION SYNDROME	0.01368523	0.6842615
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.013664382000000003	0.6832191000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.013664382000000003	0.6832191000000001
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.013411303	0.6705651499999999
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.013400290999999998	0.6700145499999999
PREECLAMPSIA/ECLAMPSIA 1	0.013400290999999998	0.6700145499999999
PROGNATHISM, MANDIBULAR	0.0133333	0.666665
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.0133333	0.666665
CRI-DU-CHAT SYNDROME	0.0133333	0.666665
NOONAN SYNDROME 4; NS4	0.0133333	0.666665
#611554 LEOPARD SYNDROME 2	0.0133333	0.666665
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.0133333	0.666665
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0133333	0.666665
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0133333	0.666665
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.0133333	0.666665
MEIER-GORLIN SYNDROME 3; MGORS3	0.0133333	0.666665
MENTAL RETARDATION, X-LINKED 19	0.0133333	0.666665
MACS SYNDROME	0.0133333	0.666665
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.013253932999999999	0.66269665
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.013253932999999999	0.66269665
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.013253932999999999	0.66269665
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.013253932999999999	0.66269665
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.013253932999999999	0.66269665
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.0129282	0.64641
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.012883513	0.64417565
BARAITSER-WINTER SYNDROME 1; BRWS1	0.012883513	0.64417565
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.012820500000000002	0.6410250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.012820500000000002	0.6410250000000001
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.012820500000000002	0.6410250000000001
IMMUNODEFICIENCY 44	0.012820500000000002	0.6410250000000001
#218800 CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME	0.012820500000000002	0.6410250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.012820500000000002	0.6410250000000001
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.012820500000000002	0.6410250000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.012820500000000002	0.6410250000000001
#606688 SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	0.012820500000000002	0.6410250000000001
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.012820500000000002	0.6410250000000001
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.012629233	0.63146165
RAYNAUD-CLAES SYNDROME; MRXSRC	0.012629233	0.63146165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.012629233	0.63146165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.012629233	0.63146165
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.012629233	0.63146165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.012629233	0.63146165
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.012629233	0.63146165
GALACTOSE EPIMERASE DEFICIENCY	0.012495552	0.6247776
NIEMANN-PICK DISEASE, TYPE A	0.012495552	0.6247776
#612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2	0.012484539999999999	0.624227
#612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4	0.012484539999999999	0.624227
#612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6	0.012484539999999999	0.624227
#612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5	0.012484539999999999	0.624227
#612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3	0.012484539999999999	0.624227
ALPORT SYNDROME, X-LINKED; ATS	0.012484539999999999	0.624227
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.012410050999999998	0.6205025499999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.012410050999999998	0.6205025499999999
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.012410050999999998	0.6205025499999999
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.012410050999999998	0.6205025499999999
KLEEFSTRA SYNDROME	0.012410050999999998	0.6205025499999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.012410050999999998	0.6205025499999999
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.012386113	0.61930565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.012386113	0.61930565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.012386113	0.61930565
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.012386113	0.61930565
BOHRING-OPITZ SYNDROME	0.012386113	0.61930565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.012386113	0.61930565
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.012386113	0.61930565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.012338182	0.6169091
BARATELA-SCOTT SYNDROME	0.012338182	0.6169091
Temtamy preaxial brachydactyly syndrome	0.012338182	0.6169091
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.012338182	0.6169091
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.012338182	0.6169091
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.012338182	0.6169091
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.012338182	0.6169091
DESBUQUOIS DYSPLASIA 2; DBQD2	0.012338182	0.6169091
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.012338182	0.6169091
HOLOPROSENCEPHALY 5; HPE5	0.012338182	0.6169091
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.012146582999999999	0.60732915
COCKAYNE SYNDROME A; CSA	0.012123761	0.60618805
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.012051892	0.6025946
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.012039631	0.60198155
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.011860633	0.59303165
ADAMS-OLIVER SYNDROME 2; AOS2	0.011860633	0.59303165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.011860633	0.59303165
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.011860633	0.59303165
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.011860633	0.59303165
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011860633	0.59303165
GLASS SYNDROME	0.011860633	0.59303165
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.011846743	0.59233715
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.011846743	0.59233715
GAUCHER DISEASE, TYPE II	0.011846743	0.59233715
AICARDI-GOUTIERES SYNDROME 7	0.011846743	0.59233715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.011785351	0.58926755
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.011785351	0.58926755
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.011785351	0.58926755
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.011746361	0.58731805
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.011713482	0.5856741000000001
HYPER-IGD SYNDROME	0.01165167	0.5825834999999999
HYPERLIPOPROTEINEMIA, TYPE I	0.01165167	0.5825834999999999
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.011542231	0.57711155
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.011542231	0.57711155
OCULOCEREBROCUTANEOUS SYNDROME	0.011542231	0.57711155
LISSENCEPHALY 3; LIS3	0.011542231	0.57711155
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.011542231	0.57711155
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.011494299999999999	0.574715
MENTAL RETARDATION, X-LINKED 97; MRX97	0.011494299999999999	0.574715
WAARDENBURG SYNDROME, TYPE 1; WS1	0.011494299999999999	0.574715
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.011494299999999999	0.574715
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.011494299999999999	0.574715
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.011494299999999999	0.574715
9q subtelomeric deletion syndrome	0.011494299999999999	0.574715
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.011494299999999999	0.574715
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.011494299999999999	0.574715
MCDONOUGH SYNDROME	0.011494299999999999	0.574715
LICHTENSTEIN SYNDROME	0.011494299999999999	0.574715
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.011494299999999999	0.574715
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.011494299999999999	0.574715
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.011494299999999999	0.574715
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.011494299999999999	0.574715
MENTAL RETARDATION, X-LINKED 73	0.011494299999999999	0.574715
CRANIOFRONTONASAL SYNDROME; CFNS	0.011470362000000001	0.5735181
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.011470362000000001	0.5735181
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.011470362	0.5735181
MICROPHTHALMIA, SYNDROMIC 3	0.011470362	0.5735181
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.011447539999999999	0.5723769999999999
MECKEL SYNDROME, TYPE 1; MKS1	0.011447539999999999	0.5723769999999999
TRIMETHYLAMINURIA	0.011208010000000001	0.5604005000000001
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.011208010000000001	0.5604005000000001
THROMBOCYTHEMIA, ESSENTIAL	0.011208010000000001	0.5604005000000001
SICKLE CELL ANEMIA	0.011208010000000001	0.5604005000000001
AMYLOIDOSIS, FAMILIAL VISCERAL	0.011208010000000001	0.5604005000000001
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.01112388	0.556194
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.01112388	0.556194
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.01112388	0.556194
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.011025682999999998	0.5512841499999999
KAPUR-TORIELLO SYNDROME	0.011016751	0.55083755
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.011016751	0.55083755
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.011016751	0.55083755
RENPENNING SYNDROME 1; RENS1	0.011016751	0.55083755
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.011002861	0.55014305
GAUCHER DISEASE, PERINATAL LETHAL	0.011002861	0.55014305
LAMB-SHAFFER SYNDROME	0.010944882000000001	0.5472441
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.010944882000000001	0.5472441
NOONAN SYNDROME 11; NS11	0.010944882000000001	0.5472441
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.010944882000000001	0.5472441
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.010944882000000001	0.5472441
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.010944882000000001	0.5472441
DYSTONIA 28, CHILDHOOD-ONSET	0.010944882000000001	0.5472441
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.010944882000000001	0.5472441
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.010944882000000001	0.5472441
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.010944882000000001	0.5472441
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.010944882000000001	0.5472441
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.010930992	0.5465496000000001
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.010884350000000001	0.5442175
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0108696	0.54348
WARBURG MICRO SYNDROME 1	0.01062648	0.531324
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.010101	0.50505
FACIAL ECTODERMAL DYSPLASIA	0.010101	0.50505
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.010101	0.50505
OROFACIAL CLEFT 15	0.010101	0.50505
260150 PALANT CLEFT PALATE SYNDROME	0.010101	0.50505
15q26 overgrowth syndrome	0.010101	0.50505
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.010101	0.50505
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.010101	0.50505
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.010101	0.50505
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.010101	0.50505
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.010101	0.50505
BARBER-SAY SYNDROME; BBRSAY	0.010101	0.50505
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.010101	0.50505
NOSE, ANOMALOUS SHAPE OF	0.010101	0.50505
#608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	0.010101	0.50505
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.010101	0.50505
OROFACIODIGITAL SYNDROME III	0.010101	0.50505
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.010101	0.50505
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.010101	0.50505
VELOCARDIOFACIAL SYNDROME	0.010101	0.50505
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.010101	0.50505
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.010101	0.50505
RUIJS-AALFS SYNDROME; RJALS	0.010101	0.50505
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.01008711	0.5043555
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.01008711	0.5043555
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.01008711	0.5043555
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.01008711	0.5043555
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.01008711	0.5043555
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.01008711	0.5043555
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.01008711	0.5043555
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.01008711	0.5043555
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.01008711	0.5043555
IMMUNODEFICIENCY 52; IMD52	0.01008711	0.5043555
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.01008711	0.5043555
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.01008711	0.5043555
EMANUEL SYNDROME	0.009425493	0.47127465
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.009006013	0.45030065
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.009006013	0.45030065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.009006013	0.45030065
ARGININOSUCCINIC ACIDURIA	0.009006013	0.45030065
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.009006013	0.45030065
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.009006013	0.45030065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.009006013	0.45030065
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.009006013	0.45030065
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.009006013	0.45030065
CHROMOSOME 19p13.13 DELETION SYNDROME	0.009006013	0.45030065
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.009006013	0.45030065
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.009006013	0.45030065
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.009006013	0.45030065
GABA-TRANSAMINASE DEFICIENCY	0.008801883	0.44009415
BAND HETEROTOPIA; BH	0.008801883	0.44009415
HOLOPROSENCEPHALY 2; HPE2	0.008801883	0.44009415
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.008801883	0.44009415
JABERI-ELAHI SYNDROME; JABELS	0.008801883	0.44009415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.008801883	0.44009415
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.008801883	0.44009415
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.008801883	0.44009415
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.008801883	0.44009415
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.008801883	0.44009415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.008801883	0.44009415
LISSENCEPHALY 4	0.008801883	0.44009415
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.008801883	0.44009415
PETERS-PLUS SYNDROME; PTRPLS	0.008801883	0.44009415
HOLOPROSENCEPHALY 7	0.008801883	0.44009415
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.008801883	0.44009415
TEMTAMY SYNDROME; TEMTYS	0.008801883	0.44009415
VICI SYNDROME; VICIS	0.008801883	0.44009415
HOLOPROSENCEPHALY 1; HPE1	0.008801883	0.44009415
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.008801883	0.44009415
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00848692	0.424346
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00848692	0.424346
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00848692	0.424346
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.008162131	0.40810654999999996
MAPLE SYRUP URINE DISEASE; MSUD	0.008162131	0.40810654999999996
PAPILLOMA OF CHOROID PLEXUS	0.008162131	0.40810654999999996
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.008162131	0.40810654999999996
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.008162131	0.40810654999999996
EPISODIC ATAXIA, TYPE 6	0.008162131	0.40810654999999996
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.008162131	0.40810654999999996
CYCLIC VOMITING SYNDROME	0.008162131	0.40810654999999996
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.008090262	0.40451310000000007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.007958001	0.39790004999999995
FRYNS SYNDROME; FRNS	0.007958001	0.39790004999999995
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.007958001	0.39790004999999995
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.007958001	0.39790004999999995
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.007958001	0.39790004999999995
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.007958001	0.39790004999999995
LISSENCEPHALY, X-LINKED, 1; LISX1	0.007958001	0.39790004999999995
BARAITSER-WINTER SYNDROME 2; BRWS2	0.007958001	0.39790004999999995
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.007958001	0.39790004999999995
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007958001	0.39790004999999995
MARDEN-WALKER SYNDROME	0.007958001	0.39790004999999995
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.007958001	0.39790004999999995
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.007958001	0.39790004999999995
CRANIOSYNOSTOSIS 6; CRS6	0.007886132	0.3943066
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.007886132	0.3943066
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.007886132	0.3943066
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.007886132	0.3943066
CURRY-JONES SYNDROME	0.007886132	0.3943066
GENITOPATELLAR SYNDROME; GTPTS	0.007886132	0.3943066
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.007886132	0.3943066
CRANIOTELENCEPHALIC DYSPLASIA	0.007886132	0.3943066
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.007886132	0.3943066
HARTSFIELD SYNDROME; HRTFDS	0.007886132	0.3943066
SEPTOOPTIC DYSPLASIA	0.007886132	0.3943066
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.007886132	0.3943066
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.007886132	0.3943066
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.007718471	0.38592355
SNEDDON SYNDROME	0.007718471	0.38592355
NEUROFIBROMATOSIS, TYPE I	0.007718471	0.38592355
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.007718471	0.38592355
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.007718471	0.38592355
Myhre syndrome	0.007718471	0.38592355
KEUTEL SYNDROME; KTLS	0.007718471	0.38592355
JOUBERT SYNDROME 14	0.007646602	0.3823301
BARDET-BIEDL SYNDROME 1; BBS1	0.007646602	0.3823301
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.007646602	0.3823301
MIRAGE SYNDROME; MIRAGE	0.007441453	0.37207265
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.007441453	0.37207265
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.007441453	0.37207265
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.007441453	0.37207265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.007441453	0.37207265
FOLATE MALABSORPTION, HEREDITARY	0.007441453	0.37207265
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007441453	0.37207265
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00724638	0.362319
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00724638	0.362319
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00724638	0.362319
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00724638	0.362319
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00724638	0.362319
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00724638	0.362319
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00724638	0.362319
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00724638	0.362319
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00724638	0.362319
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00724638	0.362319
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00724638	0.362319
LESCH-NYHAN SYNDROME; LNS	0.00724638	0.362319
EPISODIC ATAXIA, TYPE 3	0.00724638	0.362319
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.00724638	0.362319
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.00724638	0.362319
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00724638	0.362319
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00724638	0.362319
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00724638	0.362319
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00724638	0.362319
PORPHYRIA, ACUTE HEPATIC	0.00724638	0.362319
ACID PHOSPHATASE DEFICIENCY	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00724638	0.362319
LIVER FAILURE, INFANTILE, TRANSIENT	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00724638	0.362319
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00724638	0.362319
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00724638	0.362319
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00724638	0.362319
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00724638	0.362319
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00724638	0.362319
VALINEMIA	0.00724638	0.362319
CHYLOMICRON RETENTION DISEASE	0.00724638	0.362319
ALPHA-METHYLACETOACETIC ACIDURIA	0.00724638	0.362319
CONGENITAL SHORT BOWEL SYNDROME	0.00724638	0.362319
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.00724638	0.362319
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00724638	0.362319
VISCERAL MYOPATHY; VSCM	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00724638	0.362319
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00724638	0.362319
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00724638	0.362319
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE III	0.00724638	0.362319
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00724638	0.362319
PORPHYRIA VARIEGATA	0.00724638	0.362319
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00724638	0.362319
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00724638	0.362319
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00724638	0.362319
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00704225	0.3521125
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00704225	0.3521125
AGNATHIA-OTOCEPHALY COMPLEX	0.00704225	0.3521125
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00704225	0.3521125
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00704225	0.3521125
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00704225	0.3521125
MECKEL SYNDROME 12; MKS12	0.00704225	0.3521125
MIRROR MOVEMENTS 1; MRMV1	0.00704225	0.3521125
OROFACIODIGITAL SYNDROME V; OFD5	0.00704225	0.3521125
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00704225	0.3521125
OROFACIODIGITAL SYNDROME XV; OFD15	0.00704225	0.3521125
FOCAL DERMAL HYPOPLASIA; FDH	0.00704225	0.3521125
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00704225	0.3521125
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00704225	0.3521125
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00704225	0.3521125
HEMIFACIAL MICROSOMIA	0.00704225	0.3521125
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00704225	0.3521125
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00704225	0.3521125
CHIARI MALFORMATION TYPE II	0.00704225	0.3521125
HYDROLETHALUS SYNDROME 1	0.00704225	0.3521125
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.00704225	0.3521125
STROMME SYNDROME; STROMS	0.00704225	0.3521125
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00704225	0.3521125
MASA SYNDROME	0.00704225	0.3521125
SCHIZENCEPHALY	0.00704225	0.3521125
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00704225	0.3521125
PSEUDOTRISOMY 13 SYNDROME	0.00704225	0.3521125
FETAL AKINESIA SYNDROME, X-LINKED	0.00704225	0.3521125
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00704225	0.3521125
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00704225	0.3521125
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00704225	0.3521125
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00704225	0.3521125
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00704225	0.3521125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00704225	0.3521125
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00680272	0.340136
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00680272	0.340136
LIDDLE SYNDROME 2; LIDLS2	0.00680272	0.340136
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00680272	0.340136
HUNTER-MACDONALD SYNDROME	0.00680272	0.340136
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00680272	0.340136
ARTERIAL TORTUOSITY SYNDROME	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00680272	0.340136
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00680272	0.340136
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	0.00680272	0.340136
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IB	0.00680272	0.340136
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00680272	0.340136
LIDDLE SYNDROME 3; LIDLS3	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00680272	0.340136
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00680272	0.340136
#605115 HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATIONIN PREGNANCY	0.00680272	0.340136
#614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 2	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00680272	0.340136
POLYCYSTIC KIDNEYS	0.00680272	0.340136
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.00680272	0.340136
NEPHRONOPHTHISIS 1	0.00680272	0.340136
XFE PROGEROID SYNDROME; XFEPS	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 3	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00680272	0.340136
#607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IA	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00680272	0.340136
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00680272	0.340136
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00680272	0.340136
SECKEL SYNDROME 10; SCKL10	0.00680272	0.340136
Paragangliomas 6	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00680272	0.340136
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00680272	0.340136
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00680272	0.340136
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00680272	0.340136
#615378 ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14	0.00680272	0.340136
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00680272	0.340136
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00680272	0.340136
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00680272	0.340136
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.00680272	0.340136
LIDDLE SYNDROME 1; LIDLS1	0.00680272	0.340136
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00680272	0.340136
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00680272	0.340136
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00680272	0.340136
ALAGILLE SYNDROME 2	0.00680272	0.340136
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00680272	0.340136
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	0.00680272	0.340136
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00680272	0.340136
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00680272	0.340136
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.00680272	0.340136
#194080 DENYS-DRASH SYNDROME; DDS;;DRASH SYNDROME;;WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;;NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES	0.00680272	0.340136
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00680272	0.340136
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00680272	0.340136
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00680272	0.340136
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00680272	0.340136
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00680272	0.340136
LONG QT SYNDROME 13; LQT13	0.00680272	0.340136
SMITH-KINGSMORE SYNDROME; SKS	0.006597571	0.32987855
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.006597571	0.32987855
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.006597571	0.32987855
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.006597571	0.32987855
THYROCEREBRORETINAL SYNDROME	0.006597571	0.32987855
PSEUDO-TORCH SYNDROME 2	0.006597571	0.32987855
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.006597571	0.32987855
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.006597571	0.32987855
LIG4 SYNDROME	0.0065257019999999995	0.3262851
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0065257019999999995	0.3262851
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0065257019999999995	0.3262851
FORSYTHE-WAKELING SYNDROME; FWS	0.0065257019999999995	0.3262851
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0065257019999999995	0.3262851
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0065257019999999995	0.3262851
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0065257019999999995	0.3262851
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.0065257019999999995	0.3262851
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0065257019999999995	0.3262851
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.006164923	0.30824615
INFANTILE SIALIC ACID STORAGE DISEASE	0.006164923	0.30824615
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.006164923	0.30824615
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.006164923	0.30824615
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.005841263	0.29206315
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.005841263	0.29206315
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.005841263	0.29206315
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.005841263	0.29206315
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.005841263	0.29206315
CHROMOSOME 10Q26 DELETION SYNDROME	0.005841263	0.29206315
SALLA DISEASE	0.005841263	0.29206315
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.00568182	0.284091
THROMBOCYTOPENIA 3	0.00568182	0.284091
EOSINOPHILIA, FAMILIAL	0.00568182	0.284091
Diamond-Blackfan anemia 1	0.00568182	0.284091
#300835 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;XLANP	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00568182	0.284091
MONOSOMY 7 OF BONE MARROW	0.00568182	0.284091
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00568182	0.284091
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00568182	0.284091
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00568182	0.284091
DK PHOCOMELIA SYNDROME	0.00568182	0.284091
NIJMEGEN BREAKAGE SYNDROME	0.00568182	0.284091
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.00568182	0.284091
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00568182	0.284091
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00568182	0.284091
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.00568182	0.284091
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00568182	0.284091
JACOBSEN SYNDROME	0.00568182	0.284091
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00568182	0.284091
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00568182	0.284091
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00568182	0.284091
THROMBOCYTOPENIA 2	0.00568182	0.284091
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.00568182	0.284091
#231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD;;GHOSAL SYNDROME	0.00568182	0.284091
#601709 QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC	0.00568182	0.284091
PLATELET SIGNAL PROCESSING DEFECT	0.00568182	0.284091
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00568182	0.284091
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00568182	0.284091
IVIC SYNDROME	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00568182	0.284091
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00568182	0.284091
PLATELET DISORDER, UNDEFINED	0.00568182	0.284091
#608404 PLATELET GLYCOPROTEIN IV DEFICIENCY;;BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;;CD36 DEFICIENCY	0.00568182	0.284091
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.00568182	0.284091
THROMBOCYTOPENIA 5; THC5	0.00568182	0.284091
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 9	0.00568182	0.284091
THROMBOCYTOPENIA, CYCLIC	0.00568182	0.284091
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00568182	0.284091
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN Ia DEFICIENCY;;GP Ia DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00568182	0.284091
FECHTNER SYNDROME	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00568182	0.284091
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.00568182	0.284091
STORMORKEN SYNDROME; STRMK	0.00568182	0.284091
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00568182	0.284091
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00568182	0.284091
SENGERS SYNDROME	0.00568182	0.284091
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00568182	0.284091
SEBASTIAN SYNDROME	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00568182	0.284091
BEEMER LETHAL MALFORMATION SYNDROME	0.00568182	0.284091
WT LIMB-BLOOD SYNDROME	0.00568182	0.284091
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.00568182	0.284091
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00568182	0.284091
FANCONI ANEMIA	0.00568182	0.284091
#612004 THROMBOCYTOPENIA 4; THC4;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	0.00568182	0.284091
THROMBOCYTOPENIA 6	0.00568182	0.284091
Bernard-Soulier syndrome	0.00568182	0.284091
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.005343863	0.26719315
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.005343863	0.26719315
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.005343863	0.26719315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.005343863	0.26719315
MENTAL RETARDATION, X-LINKED 104; MRX104	0.005343863	0.26719315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.005343863	0.26719315
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005343863	0.26719315
Xq28 (MECP2) duplication	0.005343863	0.26719315
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.005343863	0.26719315
LISSENCEPHALY 8; LIS8	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.005343863	0.26719315
CODAS SYNDROME	0.005343863	0.26719315
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.005343863	0.26719315
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.005343863	0.26719315
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005343863	0.26719315
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.005343863	0.26719315
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.005343863	0.26719315
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.005343863	0.26719315
611961 STEVENSON-CAREY SYNDROME	0.005343863	0.26719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.005343863	0.26719315
ZTTK SYNDROME; ZTTKS	0.005343863	0.26719315
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.005343863	0.26719315
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.005343863	0.26719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.005343863	0.26719315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.005343863	0.26719315
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.005343863	0.26719315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.005343863	0.26719315
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005343863	0.26719315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.005343863	0.26719315
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.005343863	0.26719315
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.005343863	0.26719315
MEHMO SYNDROME; MEHMO	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.005343863	0.26719315
NEURAMINIDASE DEFICIENCY	0.005321041	0.26605205000000004
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.005321041	0.26605205000000004
GAUCHER DISEASE, TYPE IIIC	0.005321041	0.26605205000000004
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.005249172	0.2624586
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.005249172	0.2624586
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.005249172	0.2624586
MACROCEPHALY/AUTISM SYNDROME	0.005249172	0.2624586
OCULOSKELETODENTAL SYNDROME; OCSKD	0.005249172	0.2624586
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.005249172	0.2624586
LYMPHEDEMA, HEREDITARY, III	0.005249172	0.2624586
ROIFMAN SYNDROME; RFMN	0.005249172	0.2624586
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.005249172	0.2624586
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004997381	0.24986905
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.004997381	0.24986905
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004997381	0.24986905
HYPERLEUCINE-ISOLEUCINEMIA	0.004997381	0.24986905
ICHTHYOSIS AND MALE HYPOGONADISM	0.004997381	0.24986905
XYLOSIDASE DEFICIENCY	0.004997381	0.24986905
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004997381	0.24986905
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004925512	0.24627559999999998
LARSEN-LIKE SYNDROME	0.004925512	0.24627559999999998
REVESZ SYNDROME	0.004925512	0.24627559999999998
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.004499981	0.22499905
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004499981	0.22499905
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.004499981	0.22499905
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.004499981	0.22499905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.004499981	0.22499905
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004499981	0.22499905
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004499981	0.22499905
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.004499981	0.22499905
WARBURG MICRO SYNDROME 3; WARBM3	0.004499981	0.22499905
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.004499981	0.22499905
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.004499981	0.22499905
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.004499981	0.22499905
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004499981	0.22499905
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.004499981	0.22499905
MENTAL RETARDATION, X-LINKED 102	0.004499981	0.22499905
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.004499981	0.22499905
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.004499981	0.22499905
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.004499981	0.22499905
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004499981	0.22499905
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.004499981	0.22499905
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.004499981	0.22499905
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.004499981	0.22499905
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.004499981	0.22499905
RETT SYNDROME, CONGENITAL VARIANT	0.004499981	0.22499905
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004428112	0.22140559999999998
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.004428112	0.22140559999999998
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.004428112	0.22140559999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.004428112	0.22140559999999998
TYSHCHENKO SYNDROME	0.004428112	0.22140559999999998
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.004428112	0.22140559999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.004428112	0.22140559999999998
JOUBERT SYNDROME 21	0.004428112	0.22140559999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004428112	0.22140559999999998
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.004428112	0.22140559999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.004428112	0.22140559999999998
JOUBERT SYNDROME 31; JBTS31	0.004428112	0.22140559999999998
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.004428112	0.22140559999999998
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.004428112	0.22140559999999998
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004428112	0.22140559999999998
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.004428112	0.22140559999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.004428112	0.22140559999999998
TURNPENNY-FRY SYNDROME; TPFS	0.004428112	0.22140559999999998
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.004428112	0.22140559999999998
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.004428112	0.22140559999999998
XIA-GIBBS SYNDROME	0.004428112	0.22140559999999998
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.004428112	0.22140559999999998
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.004428112	0.22140559999999998
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.004428112	0.22140559999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004428112	0.22140559999999998
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.004428112	0.22140559999999998
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00440529	0.2202645
HYPERLIPOPROTEINEMIA, TYPE ID	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 1; SPH1	0.00440529	0.2202645
PROTEUS SYNDROME	0.00440529	0.2202645
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00440529	0.2202645
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00440529	0.2202645
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.00440529	0.2202645
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00440529	0.2202645
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00440529	0.2202645
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.00440529	0.2202645
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00440529	0.2202645
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00440529	0.2202645
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00440529	0.2202645
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00440529	0.2202645
REYNOLDS SYNDROME	0.00440529	0.2202645
HEMOGLOBIN--BETA LOCUS	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.00440529	0.2202645
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00440529	0.2202645
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00440529	0.2202645
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.00440529	0.2202645
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00440529	0.2202645
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00440529	0.2202645
APOLIPOPROTEIN C-II DEFICIENCY	0.00440529	0.2202645
NEPHRONOPHTHISIS 19; NPHP19	0.00440529	0.2202645
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00440529	0.2202645
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00440529	0.2202645
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00440529	0.2202645
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.00440529	0.2202645
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00440529	0.2202645
FELTY SYNDROME	0.00440529	0.2202645
#612690 SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5	0.00440529	0.2202645
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00440529	0.2202645
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00440529	0.2202645
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.00440529	0.2202645
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00440529	0.2202645
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.00440529	0.2202645
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.00440529	0.2202645
IMMUNODEFICIENCY 60; IMD60	0.00440529	0.2202645
ELLIPTOCYTOSIS 1; EL1	0.00440529	0.2202645
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00440529	0.2202645
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00440529	0.2202645
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00440529	0.2202645
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00440529	0.2202645
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00440529	0.2202645
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00440529	0.2202645
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00440529	0.2202645
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00440529	0.2202645
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.00440529	0.2202645
#269840 SELECTIVE T-CELL DEFECT; STCD	0.00440529	0.2202645
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.00440529	0.2202645
CASPASE 8 DEFICIENCY	0.00440529	0.2202645
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00440529	0.2202645
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00440529	0.2202645
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00440529	0.2202645
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.00440529	0.2202645
IMMUNODEFICIENCY 16	0.00440529	0.2202645
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00440529	0.2202645
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00440529	0.2202645
#612653 SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4	0.00440529	0.2202645
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00440529	0.2202645
#615513 IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;P110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY,AND IMMUNODEFICIENCY; PASLI	0.00440529	0.2202645
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00440529	0.2202645
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00440529	0.2202645
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00440529	0.2202645
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00440529	0.2202645
GLYCOPROTEIN STORAGE DISEASE	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 2	0.00440529	0.2202645
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00440529	0.2202645
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.00440529	0.2202645
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00408163	0.2040815
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.2040815
PERRY SYNDROME	0.00408163	0.2040815
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.2040815
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.2040815
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.2040815
ALKAPTONURIA	0.00408163	0.2040815
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00408163	0.2040815
LYMPHOKINE DEFICIENCY	0.00408163	0.2040815
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.2040815
AREDYLD	0.00408163	0.2040815
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.2040815
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.2040815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.2040815
GLUTATHIONE REDUCTASE	0.00408163	0.2040815
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.2040815
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.2040815
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.2040815
ICHTHYOSIS, X-LINKED	0.00408163	0.2040815
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.2040815
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00408163	0.2040815
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.2040815
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.2040815
XANTHINURIA, TYPE I	0.00408163	0.2040815
DERMATOLEUKODYSTROPHY	0.00408163	0.2040815
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.2040815
PITUITARY DWARFISM IV	0.00408163	0.2040815
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.2040815
ONCOCYTOMA	0.00408163	0.2040815
PREMATURE OVARIAN FAILURE 1	0.00408163	0.2040815
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.2040815
HOOFT DISEASE	0.00408163	0.2040815
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.2040815
GLOMUVENOUS MALFORMATIONS	0.00408163	0.2040815
EHLERS-DANLOS SYNDROME, TYPE VI	0.00408163	0.2040815
ACETYLATION, SLOW	0.00408163	0.2040815
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.2040815
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.2040815
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.2040815
SPINAL ARACHNOIDITIS	0.00408163	0.2040815
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.2040815
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.2040815
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.2040815
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.2040815
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.2040815
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.2040815
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.2040815
LIPASE DEFICIENCY, COMBINED	0.00408163	0.2040815
NEPHROSIALIDOSIS	0.00408163	0.2040815
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00408163	0.2040815
GONADOBLASTOMA	0.00408163	0.2040815
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.2040815
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.2040815
BEETURIA	0.00408163	0.2040815
PARAOXONASE 1	0.00408163	0.2040815
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00408163	0.2040815
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.2040815
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.2040815
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.2040815
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.2040815
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.2040815
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.2040815
PENDRED SYNDROME	0.00408163	0.2040815
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.2040815
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.2040815
HYPERPROGLUCAGONEMIA	0.00408163	0.2040815
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.2040815
CARBOXYLESTERASE 1	0.00408163	0.2040815
DELETED IN AZOOSPERMIA	0.00408163	0.2040815
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.2040815
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00408163	0.2040815
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.2040815
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.2040815
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.2040815
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.2040815
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.2040815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.2040815
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.2040815
GLUTATHIONURIA	0.00408163	0.2040815
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.2040815
CALVARIAL HYPEROSTOSIS	0.00408163	0.2040815
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.2040815
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.2040815
LARON SYNDROME	0.00408163	0.2040815
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.2040815
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.2040815
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.2040815
ZINC, ELEVATED PLASMA	0.00408163	0.2040815
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00408163	0.2040815
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00408163	0.2040815
FINGERPRINT BODY MYOPATHY	0.00408163	0.2040815
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.2040815
APOLIPOPROTEIN(A)	0.00408163	0.2040815
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.2040815
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00408163	0.2040815
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.2040815
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.2040815
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.2040815
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.2040815
DERMATITIS, ATOPIC	0.00408163	0.2040815
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.2040815
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.2040815
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.2040815
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.2040815
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.2040815
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.2040815
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.2040815
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00408163	0.2040815
ALAND ISLAND EYE DISEASE	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.2040815
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.2040815
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.2040815
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.2040815
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.2040815
PYGMY	0.00408163	0.2040815
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.2040815
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.2040815
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.2040815
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.2040815
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.2040815
SCHIZOPHRENIA 4	0.00408163	0.2040815
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.2040815
OVARIAN CANCER	0.00408163	0.2040815
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.2040815
TRISOMY 18-LIKE SYNDROME	0.00408163	0.2040815
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.2040815
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.2040815
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00408163	0.2040815
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.2040815
T-SUBSTANCE ANOMALY	0.00408163	0.2040815
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.2040815
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.2040815
HYPOASCORBEMIA	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.2040815
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.2040815
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.2040815
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.2040815
XM SYSTEM	0.00408163	0.2040815
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.2040815
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.2040815
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.2040815
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.2040815
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.2040815
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.2040815
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.2040815
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.2040815
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00408163	0.2040815
MYOPATHY, SPHEROID BODY	0.00408163	0.2040815
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.2040815
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.2040815
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.2040815
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.2040815
PACMAN DYSPLASIA	0.00408163	0.2040815
OSTEOGENIC SARCOMA	0.00408163	0.2040815
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.2040815
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.2040815
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.2040815
PROGESTERONE RESISTANCE	0.00408163	0.2040815
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.2040815
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.2040815
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.2040815
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.2040815
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.2040815
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.2040815
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.2040815
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.2040815
HEINZ BODY ANEMIAS	0.00408163	0.2040815
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.2040815
CITRULLINE TRANSPORT DEFECT	0.00408163	0.2040815
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00408163	0.2040815
ETHANOLAMINOSIS	0.00408163	0.2040815
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00358423	0.1792115
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00358423	0.1792115
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.00358423	0.1792115
MECKEL SYNDROME, TYPE 4; MKS4	0.00358423	0.1792115
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00358423	0.1792115
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00358423	0.1792115
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00358423	0.1792115
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00358423	0.1792115
ANIRIDIA	0.00358423	0.1792115
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00358423	0.1792115
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00358423	0.1792115
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00358423	0.1792115
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00358423	0.1792115
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00358423	0.1792115
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00358423	0.1792115
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00358423	0.1792115
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00358423	0.1792115
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00358423	0.1792115
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00358423	0.1792115
CEREBROOCULONASAL SYNDROME	0.00358423	0.1792115
FRONTONASAL DYSPLASIA 2; FND2	0.00358423	0.1792115
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00358423	0.1792115
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00358423	0.1792115
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001759633	0.08798165
SULFOCYSTEINURIA	0.001759633	0.08798165
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.08798165
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.001759633	0.08798165
KETOADIPICACIDURIA	0.001759633	0.08798165
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.08798165
PRADER-WILLI SYNDROME; PWS	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.08798165
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001759633	0.08798165
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.001759633	0.08798165
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.08798165
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001759633	0.08798165
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.08798165
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.08798165
LUSCAN-LUMISH SYNDROME; LLS	0.001759633	0.08798165
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.08798165
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001759633	0.08798165
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.08798165
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.08798165
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001759633	0.08798165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001759633	0.08798165
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001759633	0.08798165
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.08798165
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.08798165
Muenke syndrome	0.001759633	0.08798165
KBG SYNDROME	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.08798165
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.08798165
SCHINDLER DISEASE, TYPE I	0.001759633	0.08798165
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001759633	0.08798165
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.08798165
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001759633	0.08798165
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.001759633	0.08798165
DIGEORGE SYNDROME; DGS	0.001759633	0.08798165
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.08798165
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.08798165
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001759633	0.08798165
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001759633	0.08798165
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001759633	0.08798165
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.08798165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001759633	0.08798165
C SYNDROME	0.001759633	0.08798165
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001759633	0.08798165
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001759633	0.08798165
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.08798165
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001759633	0.08798165
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001759633	0.08798165
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.08798165
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001759633	0.08798165
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001759633	0.08798165
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001759633	0.08798165
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.08798165
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001759633	0.08798165
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001759633	0.08798165
Pierpont syndrome	0.001759633	0.08798165
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.08798165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001759633	0.08798165
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001759633	0.08798165
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.08798165
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.08798165
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001759633	0.08798165
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.08798165
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001759633	0.08798165
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001759633	0.08798165
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.08798165
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.08798165
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001759633	0.08798165
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001759633	0.08798165
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001759633	0.08798165
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001759633	0.08798165
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001759633	0.08798165
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001759633	0.08798165
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001759633	0.08798165
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.08798165
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001759633	0.08798165
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001759633	0.08798165
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001759633	0.08798165
TIMOTHY SYNDROME; TS	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001759633	0.08798165
SCHAAF-YANG SYNDROME; SHFYNG	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.08798165
CHROMOSOME 1p35 DELETION SYNDROME	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001759633	0.08798165
IMMUNODEFICIENCY 49; IMD49	0.001759633	0.08798165
WAISMAN SYNDROME; WSMN	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.08798165
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001759633	0.08798165
MACDERMOT-WINTER SYNDROME	0.001759633	0.08798165
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001759633	0.08798165
CATEL-MANZKE SYNDROME; CATMANS	0.001759633	0.08798165
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001759633	0.08798165
WIEACKER-WOLFF SYNDROME	0.001759633	0.08798165
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.08798165
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001759633	0.08798165
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.08798165
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.08798165
ANGELMAN SYNDROME	0.001759633	0.08798165
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.08798165
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001759633	0.08798165
CHROMOSOME 5Q12 DELETION SYNDROME	0.001759633	0.08798165
MEND SYNDROME; MEND	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.08798165
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001759633	0.08798165
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001759633	0.08798165
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001759633	0.08798165
LANDAU-KLEFFNER SYNDROME	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001759633	0.08798165
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.08798165
SHUKLA-VERNON SYNDROME; SHUVER	0.001759633	0.08798165
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001759633	0.08798165
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.08798165
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001759633	0.08798165
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.08798165
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.08798165
PHACE ASSOCIATION	0.001759633	0.08798165
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001759633	0.08798165
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001759633	0.08798165
WEAVER SYNDROME	0.001759633	0.08798165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.08798165
LEIGH SYNDROME; LS	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 90	0.001759633	0.08798165
Cerebral creatine deficiency syndrome 2	0.001759633	0.08798165
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.08798165
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001759633	0.08798165
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.08798165
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.08798165
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001759633	0.08798165
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.001759633	0.08798165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001759633	0.08798165
CHROMOSOME 16p13.3 DELETION SYNDROME	0.001759633	0.08798165
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.08798165
CHROMOSOME 2q37 DELETION SYNDROME	0.001759633	0.08798165
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.08798165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.08798165
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.08798165
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001759633	0.08798165
ELEJALDE DISEASE	0.001759633	0.08798165
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001759633	0.08798165
CHROMOSOME 16p13.2 DELETION SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.08798165
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.08798165
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.08798165
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.08798165
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001759633	0.08798165
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001759633	0.08798165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.08798165
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.08798165
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.08798165
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.08798165
OCULOECTODERMAL SYNDROME; OES	0.001759633	0.08798165
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.08798165
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001759633	0.08798165
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.08798165
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.08798165
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.08798165
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.08798165
KLEEFSTRA SYNDROME 2; KLEFS2	0.001759633	0.08798165
INFANTILE LIVER FAILURE SYNDROME 1	0.001759633	0.08798165
PELIZAEUS-MERZBACHER DISEASE	0.001759633	0.08798165
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001759633	0.08798165
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.001759633	0.08798165
PALLISTER-HALL SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.08798165
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001759633	0.08798165
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001759633	0.08798165
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001759633	0.08798165
HARTNUP DISORDER	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.08798165
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.08798165
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001759633	0.08798165
Glycosylphosphatidylinositol biosynthesis defect 18	0.001759633	0.08798165
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001759633	0.08798165
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001759633	0.08798165
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001759633	0.08798165
SHASHI-PENA SYNDROME; SHAPNS	0.001759633	0.08798165
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.08798165
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.08798165
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.08798165
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001759633	0.08798165
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001759633	0.08798165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001759633	0.08798165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001759633	0.08798165
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.08798165
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.08798165
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.04578755
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.04578755
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.04578755
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.04578755
COFFIN-LOWRY SYNDROME; CLS	0.000915751	0.04578755
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.04578755
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.04578755
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.04578755
1p36 microdeletion syndrome	0.000915751	0.04578755
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.04578755
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.04578755
TAY-SACHS DISEASE; TSD	0.000915751	0.04578755
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.04578755
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.04578755
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.04578755
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.04578755
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.04578755
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.04578755
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.04578755
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.04578755
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.04578755
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.04578755
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.04578755
INCONTINENTIA PIGMENTI; IP	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.04578755
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.04578755
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.04578755
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.04578755
PALLISTER-KILLIAN SYNDROME	0.000915751	0.04578755
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.04578755
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.04578755
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.04578755
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.04578755
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.04578755
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.04578755
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.04578755
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.04578755
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.04578755
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.04578755
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.04578755
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.04578755
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.04578755
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.04578755
DARIER-WHITE DISEASE; DAR	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.04578755
OHDO SYNDROME	0.000915751	0.04578755
DYSOSTEOSCLEROSIS	0.000915751	0.04578755
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.04578755
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.04578755
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.04578755
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.04578755
ALEXANDER DISEASE	0.000915751	0.04578755
Angelman syndrome (Type 1)	0.000915751	0.04578755
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.04578755
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.04578755
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.04578755
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.04578755
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000915751	0.04578755
HHHH SYNDROME	0.000915751	0.04578755
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000915751	0.04578755
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.04578755
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.04578755
RAMON SYNDROME	0.000915751	0.04578755
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.04578755
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.04578755
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.04578755
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.04578755
FILIPPI SYNDROME; FLPIS	0.000915751	0.04578755
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.04578755
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000915751	0.04578755
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.04578755
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000915751	0.04578755
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.04578755
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.04578755
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.04578755
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.04578755
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.04578755
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.04578755
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.04578755
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.04578755
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.04578755
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.04578755
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.04578755
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.04578755
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.04578755
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.04578755
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.04578755
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.04578755
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.04578755
2q33.1 deletion syndrome	0.000915751	0.04578755
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000915751	0.04578755
KUFOR-RAKEB SYNDROME	0.000915751	0.04578755
HYPER-BETA-ALANINEMIA	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.04578755
Wolf-Hirschhorn Syndrome	0.000915751	0.04578755
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.04578755
DIAMINOPENTANURIA	0.000915751	0.04578755
THREONINEMIA	0.000915751	0.04578755
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.04578755
POTOCKI-SHAFFER SYNDROME	0.000915751	0.04578755
BRANCHIOOCULOFACIAL SYNDROME	0.000915751	0.04578755
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.04578755
TENORIO SYNDROME; TNORS	0.000915751	0.04578755
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.04578755
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.04578755
AUTISM	0.000915751	0.04578755
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.04578755
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.04578755
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.04578755
RETT SYNDROME; RTT	0.000915751	0.04578755
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.04578755
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.04578755
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.04578755
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000915751	0.04578755
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.04578755
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.04578755
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.04578755
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.04578755
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.04578755
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.04578755
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.04578755
PARIETAL FORAMINA	0.000915751	0.04578755
KIFAFA SEIZURE DISORDER	0.000915751	0.04578755
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.04578755
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.04578755
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.04578755
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.04578755
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.04578755
STURGE-WEBER SYNDROME	0.000915751	0.04578755
CRANIOSYNOSTOSIS 2	0.000915751	0.04578755
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.04578755
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000915751	0.04578755
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.000915751	0.04578755
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.04578755
GURRIERI SYNDROME	0.000915751	0.04578755
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.04578755
FLYNN-AIRD SYNDROME	0.000915751	0.04578755
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.04578755
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.04578755
Angelman syndrome (Type 2)	0.000915751	0.04578755
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.04578755
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.04578755
PHENYLKETONURIA	0.000915751	0.04578755
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.04578755
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.04578755
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.04578755
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.04578755
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.04578755
SECKEL SYNDROME 1; SCKL1	0.000915751	0.04578755
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.04578755
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.04578755
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.04578755
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.04578755
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.04578755
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.04578755
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000915751	0.04578755
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.04578755
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.04578755
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.04578755
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.04578755
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000915751	0.04578755
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.04578755
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.04578755
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.04578755
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.04578755
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.04578755
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.04578755
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.04578755
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000915751	0.04578755
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.04578755
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.04578755
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.04578755
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.04578755
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.04578755
CROUZON SYNDROME	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.04578755
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.04578755
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.04578755
PAPILLORENAL SYNDROME	0.000915751	0.04578755
HUNTINGTON DISEASE; HD	0.000915751	0.04578755
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.04578755
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.04578755
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.04578755
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.04578755
PERRAULT SYNDROME 3	0.000915751	0.04578755
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.04578755
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.04578755
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.04578755
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.04578755
HYPERLYSINEMIA, TYPE I	0.000915751	0.04578755
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.04578755
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.04578755
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.04578755
ALZHEIMER DISEASE 3; AD	0.000915751	0.04578755
EPILEPSY, READING	0.000915751	0.04578755
HYPERPROLINEMIA, TYPE II	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.04578755
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.04578755
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000915751	0.04578755
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000915751	0.04578755
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.04578755
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.04578755
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.0421941
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.0421941
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.0421941
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.0421941
SECKEL SYNDROME 9; SCKL9	0.000843882	0.0421941
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.0421941
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.0421941
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.0421941
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000843882	0.0421941
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.0421941
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.0421941
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000843882	0.0421941
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.0421941
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.0421941
NOONAN SYNDROME 2; NS2	0.000843882	0.0421941
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.0421941
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.0421941
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.0421941
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.0421941
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.0421941
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.0421941
NOONAN SYNDROME 3; NS3	0.000843882	0.0421941
PELLAGRA-LIKE SYNDROME	0.000843882	0.0421941
MARINESCO-SJOGREN SYNDROME; MSS	0.000843882	0.0421941
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.0421941
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.0421941
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.0421941
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.0421941
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.0421941
ARIMA SYNDROME	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.0421941
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.0421941
SENIOR-LOKEN SYNDROME 9	0.000843882	0.0421941
JOUBERT SYNDROME 1	0.000843882	0.0421941
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.0421941
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.0421941
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.0421941
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000843882	0.0421941
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000843882	0.0421941
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.0421941
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.0421941
TOWNES-BROCKS SYNDROME 1; TBS1	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.0421941
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.0421941
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.0421941
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.0421941
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.0421941
STEEL SYNDROME; STLS	0.000843882	0.0421941
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.000843882	0.0421941
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.0421941
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.0421941
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.0421941
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.0421941
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.0421941
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.0421941
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.0421941
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.0421941
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.0421941
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.0421941
MEIER-GORLIN SYNDROME 7	0.000843882	0.0421941
JOUBERT SYNDROME 15	0.000843882	0.0421941
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.0421941
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.0421941
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.0421941
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.0421941
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000843882	0.0421941
JOUBERT SYNDROME 27	0.000843882	0.0421941
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.0421941
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.0421941
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.0421941
AUSTRALIA ANTIGEN	0.000843882	0.0421941
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.0421941
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.0421941
NOONAN SYNDROME 6; NS6	0.000843882	0.0421941
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.0421941
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.0421941
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.0421941
Aarskog-Scott syndrome	0.000843882	0.0421941
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.0421941
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.0421941
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.0421941
#300555 DENT DISEASE 2	0.000843882	0.0421941
Bardet-Biedl syndrome 2	0.000843882	0.0421941
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.0421941
CHAR SYNDROME	0.000843882	0.0421941
WAARDENBURG-SHAH SYNDROME	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.0421941
CURRARINO SYNDROME	0.000843882	0.0421941
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.0421941
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.0421941
LOWRY-MACLEAN SYNDROME	0.000843882	0.0421941
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.0421941
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.0421941
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000843882	0.0421941
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.0421941
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.0421941
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.0421941
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.0421941
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.0421941
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.0421941
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.0421941
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.0421941
Jawad syndrome	0.000843882	0.0421941
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.0421941
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.0421941
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.0421941
JOUBERT SYNDROME 6	0.000843882	0.0421941
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.0421941
OROTIC ACIDURIA	0.000843882	0.0421941
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.0421941
FRONTOOCULAR SYNDROME	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.0421941
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.000843882	0.0421941
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.0421941
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000843882	0.0421941
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.0421941
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.0421941
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.0421941
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.0421941
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.0421941
CHROMOSOME 9P DELETION SYNDROME	0.000843882	0.0421941
FRIAS SYNDROME	0.000843882	0.0421941
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.0421941
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.0421941
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.0421941
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.0421941
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.0421941
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.0421941
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.0421941
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.0421941
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.0421941
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.0421941
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME VI	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.0421941
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.0421941
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.0421941
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.0421941
JOUBERT SYNDROME 24	0.000843882	0.0421941
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000843882	0.0421941
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.0421941
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.0421941
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.0421941
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000843882	0.0421941
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.0421941
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.0421941
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.0421941
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.0421941
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.0421941
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000843882	0.0421941
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000843882	0.0421941
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.0421941
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000843882	0.0421941
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.0421941
AU-KLINE SYNDROME; AUKS	0.000843882	0.0421941
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.0421941
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.0421941
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.0421941
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.0421941
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.0421941
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.0421941
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.0421941
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.0421941
CULLER-JONES SYNDROME; CJS	0.000843882	0.0421941
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.0421941
CDAGS SYNDROME	0.000843882	0.0421941
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.0421941
#614976 CARPENTER SYNDROME 2; CRPT2	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.0421941
WARSAW BREAKAGE SYNDROME; WABS	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000843882	0.0421941
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000843882	0.0421941
JOUBERT SYNDROME 25	0.000843882	0.0421941
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.0421941
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.0421941
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.0421941
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000843882	0.0421941
3MC SYNDROME 2	0.000843882	0.0421941
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.0421941
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.0421941
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.0421941
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.0421941
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000843882	0.0421941
RAHMAN SYNDROME	0.000843882	0.0421941
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.0421941
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000843882	0.0421941
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.0421941
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.0421941
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.0421941
AL-RAQAD SYNDROME; ARS	0.000843882	0.0421941
Leukotriene C4 synthase deficiency	0.000843882	0.0421941
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.0421941
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000843882	0.0421941
JOUBERT SYNDROME 8	0.000843882	0.0421941
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.0421941
NETHERTON SYNDROME; NETH	0.000843882	0.0421941
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.0421941
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.0421941
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.0421941
JOUBERT SYNDROME 26	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000843882	0.0421941
MECKEL SYNDROME 13; MKS13	0.000843882	0.0421941
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.0421941
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.0421941
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.0421941
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.0421941
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000843882	0.0421941
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
SECKEL SYNDROME 8; SCKL8	0.000843882	0.0421941
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.0421941
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.0421941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.0421941
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.0421941
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.0421941
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.0421941
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.0421941
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.0421941
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
Cerebral creatine deficiency syndrome 3	0.000843882	0.0421941
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000843882	0.0421941
COHEN-GIBSON SYNDROME; COGIS	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.0421941
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.0421941
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.0421941
COFFIN-SIRIS SYNDROME 7; CSS7	0.000843882	0.0421941
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.0421941
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.0421941
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.0421941
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.0421941
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.0421941
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.0421941
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.0421941
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.0421941
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.0421941
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000843882	0.0421941
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.0421941
NOONAN SYNDROME 9; NS9	0.000843882	0.0421941
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000843882	0.0421941
BAKER-GORDON SYNDROME; BAGOS	0.000843882	0.0421941
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.0421941
RAINE SYNDROME	0.000843882	0.0421941
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.0421941
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.0421941
JOUBERT SYNDROME 28	0.000843882	0.0421941
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.0421941
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.0421941
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000843882	0.0421941
IMMUNODEFICIENCY 23; IMD23	0.000843882	0.0421941
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.0421941
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.0421941
